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SCOPE AND OUTLINE OF THE THESIS 
The present thesis reports the works performed at The Biofilm Group Lab at IBB - Institute for 
Biotechnology and Bioengineering, Centre of Biological Engineering, Universidade do Minho, 
Braga, Portugal, and at Thierry Jouenne BRICs Group, Laboratory “Polymères, Biopolymères, 
Surfaces”, UMR 6270 CNRS, at the University of Rouen, France. 
This thesis is organized into six chapters. The first chapter briefly reviews relevant aspects of 
Pseudomonas aeruginosa virulence factors and biofilm formation and summarizes the state-of-
the-art knowledge on antimicrobial resistance in planktonic and biofilm cells. In Chapter 2, the 
microorganisms, materials and methods used in the work presented herein are summarized. 
Chapter 3 reports some studies with P. aeruginosa clinical isolates, regarding their motility, 
biofilm-formation ability and associated biofilm antimicrobial tolerance (Chapter 3.1), as well as 
on the biofilm recovery after selective pressure of antibiotics (Chapter 3.2). The fourth chapter 
focuses on the phenotypic characterization of the adaptive resistance induced in bacteria in the 
planktonic (Chapter 4.1) and biofilm state (Chapter 4.2). Chapter 5 resumes all the proteomic 
studies performed throughout this work, which comprises the outer membrane proteins 
characterization of planktonic (Chapter 5.1) and biofilm-entrapped P. aeruginosa (Chapter 5.2) 
after adaptation to antimicrobials. Finally Chapter 6 provides general conclusions of the work 
presented in this thesis and proposes future research lines. 
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ABSTRACT 
Several studies have recognised that bacteria present higher resistance to antimicrobials when switching 
from planktonic to biofilm mode of life. However, the phenotypic and proteomic changes associated with 
the reduced susceptibility of biofilms to antimicrobials are still poorly described.  
The goal of this work was to extend the understanding about the biofilm-augmented tolerance of 
Pseudomonas aeruginosa, an opportunistic pathogen that exhibits intrinsic resistance to several 
antimicrobial agents, and shows great aptitude to acquire adaptive resistance to environmental pressures. 
The experimental analysis was two-fold: a phenotypical examination comprising the initial adhesion ability, 
biofilm formation and susceptibility to antimicrobial agents, and a proteomic characterisation of the outer 
membrane (OM) proteins in planktonic and biofilm modes of growth. In order to best reproduce real-world 
situations and explore cell adaptive resistance, the study covered several P. aeruginosa strains, namely: a 
reference strain (ATCC 10145), an endoscope surface isolate, four clinical isolates inherently exposed to 
real pressures, and a laboratory-adapted strain obtained in vitro by sequential exposure to increasing 
concentrations of benzalkonium chloride (BC). As biofilms can comprise more than one species, and the 
interactions between microorganisms can enhance biofilm survival and resistance, Escherichia coli was used 
to form mixed biofilms. The phenotypical examination accounted for susceptibility to the BC and antibiotics 
Ciprofloxacin (CIP) and Gentamicin (GM) whilst the proteome of the OM of BC-adapted P. aeruginosa was 
characterised in planktonic and biofilm modes of growth. 
Motility has been pinpointed as an important factor for P. aeruginosa adhesion and biofilm development, 
this trait being also associated with increased microorganism virulence. Each P. aeruginosa clinical isolate 
revealed specific ability to develop biofilm and to move along a surface, as well as specific biofilm response 
to the presence of BC and CIP. However, it was not possible to clearly establish direct relationships between 
higher motility and biofilm formation ability and increased resistance. The variability of behaviour observed 
between the clinical isolates has called attention to the need to develop and adopt standardized operational 
procedures to evaluate biofilm formation capacity, as well as its sensitivity to in-use antimicrobials.  
Bacteria aptitude to become dormant when exposed to antimicrobial agents was also characterized as a 
possible mechanism of virulence. Biofilms formed by the endoscope-isolated P. aeruginosa were exposed to 
intermittent cycles of high-doses of CIP and GM to assess the so-called post-antibiotic effect. At the end of 
each stress cycle, the remaining cells were able to regrowth and reconstitute the biofilm, achieving values of 
the same magnitude of those obtained when biofilms were developed in the absence of antibiotics. So, it is 
conceivable to think that biofilm-growing P. aeruginosa strains possess high capacity to survive to external 
antibiotic pressure. Indeed, it is believed that such pressure acts as a selector of persister cells that are able to 
recolonize the surface contributing to increased biofilm recalcitrance. 
The effect of antimicrobials on P. aeruginosa early-adhesion was detailed by studying the impact of BC 
residue deposition on the adhesion surfaces, as well as on the bacteria surface properties. Results showed 
that the presence of BC alters the thermodynamic properties of bacteria and adhesion surfaces, favouring 
adhesion and promoting biofilm formation. So, to prevent bacterial outbreaks and disinfection practice 
failures, special care should be taken with the design of effective sanitation programs avoiding antimicrobial 
residues accumulation. 
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The existence within a biofilm of multiple bacterial species can assist interspecies relationships, which 
might stimulate biofilm development and increase stability, and thus augment resistance. Studies with P. 
aeruginosa and E. coli showed that the continuous exposure of biofilms to sub-lethal concentrations of BC 
induced an adaptive response of both bacteria, stimulating biofilm formation and the overproduction of a 
denser and cohesive matrix. Data emphasised that the use of inappropriate doses of antimicrobials can, 
instead of kill sessile microorganisms and remove them from the surfaces, lead to the development of 
biofilms encompassing more virulent bacteria. 
Resistance mechanisms are often related with changes in membrane permeability and differential expression 
of efflux-pumps and porins. The proteomic analysis of the outer membrane (membranome) of BC-adapted 
P. aeruginosa revealed differences in the expression of a small number of proteins after planktonic adaptive 
selection. Results suggest that planktonic bacterial adaptation does not mobilize transport systems at 
membranome level. Biofilm proteomic studies revealed that adaptation to BC and CIP promotes the down-
regulation of several proteins, suggesting a shared resistance response of P. aeruginosa to the action of both 
antimicrobials. The differentially expressed proteins are related to: pilus formation (type IV pilus 
biogenesis), which affects motility and adhesion; membrane vesicle production (putative tail sheath protein 
and bacteriophage protein), which is known to contain active toxins and other virulence factors; and 
unknown function (major capsid protein), encoded by genes belonging to the genomic island PAGI-6, a 
prophage that has undergone multiple recombination and deletion events resulting in altered virulence. The 
different expression of these proteins may be on the basis of the emergence of small colony variants or 
sticky strains in biofilms, the increased P. aeruginosa virulence emphasised by higher adhesion, 
hydrophobicity, swimming and twitching motilities and also biofilm ability to survive under chemical stress 
conditions.  
This work contributed significantly to the phenotypic and proteomic understanding of P. aeruginosa biofilm 
tolerance. It was concluded that resistance is strain-dependent and in close association with the surrounding 
environmental stresses. Moreover, the exposure to environmental stressors dictated P. aeruginosa 
recalcitrance and enhancement of bacteria virulence factors. This knowledge will undoubtedly assist the 
development of new and more effective strategies to control biofilm formation and treatment regimens to 
eradicate biofilm-growing bacteria. 
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RESUMO 
Nos últimos anos, vários estudos têm demonstrado que as bactérias quando crescidas na forma de biofilme 
apresentam uma resistência antimicrobiana superior à observada em crescimento planctónico. Contudo, as 
alterações fenotípicas e proteómicas associadas à diminuição de susceptibilidade aos produtos 
antimicrobianos das bactérias quando constituídas em biofilme ainda não estão completamente 
caracterizadas e descritas.  
Neste cenário, este trabalho teve como objectivo contribuir para o conhecimento acerca do aumento da 
tolerância aos produtos antimicrobianos oferecida pelos biofilmes formados por Pseudomonas aeruginosa, 
uma bactéria patogénica que apresenta frequentemente elevada resistência intrínseca a agentes 
antimicrobianos e grande aptidão para adquirir resistência adaptativa em resposta a pressões ambientais 
externas.  
 De modo a compreender o comportamento de bactérias em biofilmes, quando expostos a pressões 
ambientais, e obter informação acerca dos mecanismos que podem estar na base da tolerância aumentada 
dos biofilmes, procedeu-se à caracterização fenotípica e proteómica de biofilmes de P. aeruginosa expostos 
a diferentes produtos antimicrobianos. Com o intuito de melhor reproduzir situações reais e explorar a 
resistência adaptativa exibida por bactérias, este trabalho incluiu várias estirpes de P. aeruginosa: uma de 
referência (ATCC 10145), uma isolada de um endoscópio, quatro isolados clínicos inerentemente expostos a 
pressões reais, e uma estirpe adaptada em laboratório por exposição sequencial a concentrações crescentes 
de cloreto de benzalcónio (BC). Uma vez que, naturalmente, os biofilmes podem ser compostos por mais do 
que uma espécie de microrganismo e que a interação entre eles pode favorecer a capacidade de 
sobrevivência e a tolerância a produtos antimicrobianos, uma estirpe de Escherichia coli foi também 
estudada de modo a desenvolver biofilmes mistos.  
A caracterização fenotípica envolveu, a determinação da susceptibilidade a BC e aos antibióticos, 
ciprofloxacina (CIP) e gentamicina (GM), enquanto que a análise proteómica compreendeu a caracterização 
das proteínas da membrana externa de bactérias de P. aeruginosa adaptadas a CB em crescimento 
planctónico e em biofilme. 
Um factor importante associado ao aumento da virulência de P. aeruginosa, com grande influência na 
adesão e formação de biofilme é a capacidade de locomoção ou motilidade. Cada isolado clínico de P. 
aeruginosa estudado revelou especificidade na sua capacidade de desenvolver biofilmes e de se mover à 
superfície, bem como na resposta dos biofilmes à presença de BC e CIP. Contudo, não foi possível 
estabelecer uma relação evidente direta entre a maior capacidade de locomoção, formação de biofilme, e 
aumento de resistência. A variabilidade de comportamentos observada alertou para a necessidade de se 
desenvolver e adotar procedimentos de operação padronizados para avaliar a capacidade de formação de 
biofilme, bem como a sua sensibilidade a produtos antimicrobianos de uso comum.  
Um outro factor de virulência bastante importante é a capacidade de as bactérias se tornarem dormentes 
quando expostas a produtos antimicrobianos. De modo a estudar esta característica, biofilmes desenvolvidos 
pela estirpe isolada do endoscópio foram expostos a ciclos intermitentes de elevadas doses de CIP e GM, 
determinando-se assim o efeito pós-antibiótico. No final de cada ciclo, as bactérias que sobreviveram foram 
capazes de recrescer e reconstituir o biofilme, alcançando valores da mesma grandeza que os biofilmes 
Proteomic and phenotypic view of P. aeruginosa resistance due to antimicrobial stress 
 
  
 
xiv 
desenvolvidos na ausência de antibióticos. Os resultados obtidos permitem especular que bactérias de P. 
aeruginosa quando crescidas em biofilme apresentam capacidade superior de sobreviver a pressões externas 
exercidas por antibióticos. Este factor de stress atuou assim como seletor de bactérias persistentes capazes de 
recolonizar superfícies o que poderá contribuir para o aumento da recalcitrância de biofilmes. 
De modo a determinar qual a ação de produtos antimicrobianos na adesão inicial de P. aeruginosa e se a 
presença destes poderá contribuir para o aumento da resistência, foi estudado o impacto da deposição de 
resíduos de BC nas propriedades das superfícies das bactérias e das superfícies de adesão. Os resultados 
obtidos mostraram que a presença de BC causa modificações nas propriedades termodinâmicas de ambas as 
superfícies. Estas alterações favoreceram a adesão, promovendo a formação de biofilme, especialmente da 
estirpe adaptada a BC. Assim, de modo a prevenir surtos bacterianos e más práticas de desinfecção, devem 
ser tomadas precauções especiais na definição e implementação de procedimentos de limpeza eficientes, 
evitando a deposição de resíduos de produtos antimicrobianos. 
A presença de múltiplas espécies de microrganismos na população que constitui o biofilme pode favorecer a 
relação entre as espécies, que poderá promover o desenvolvimento do biofilmes e aumentar a sua 
estabilidade, desenvolvendo assim a sua resistência. Os estudos efectuados com biofilmes mistos de P. 
aeruginosa e E. coli mostraram que a exposição contínua a concentrações sub letais de BC induziu uma 
resposta adaptativa dos biofilmes. Esta adaptação provocou um aumento da capacidade de formação de 
biofilme, e a elevada produção e coesão da matriz polimérica. Os dados obtidos enfatizaram que o uso de 
doses inapropriadas de produtos antimicrobianos poderá, em vez de inativar os microrganismos e eliminá-
los das superfícies, promover o desenvolvimento de biofilmes constituídos por bactérias mais virulentas. 
Os mecanismos de resistência estão frequentemente associados a alterações da permeabilidade da membrana 
e expressão diferencial de proteínas de bombas de efluxo e porinas. Assim, de modo a compreender se a 
estirpe adaptada a BC apresenta alterações a nível proteico, vários estudos proteómicos foram efectuados. A 
análise proteómica das proteínas da membrana (membranoma) de bactérias de P. aeruginosa adaptadas a 
BC em crescimento planctónico revelou diferenças na expressão de um reduzido número de proteínas após 
seleção por adaptação. Os resultados obtidos sugerem que a adaptação bacteriana a BC em estado 
planctónico não parece mobilizar sistemas de transporte ao nível da membrana externa. Os perfis proteicos 
das bactérias de P. aeruginosa adaptadas em biofilme mostraram que, a adaptação a BC e a CIP causou a 
subexpressão de algumas proteínas. A expressão comum poderá indicar uma possível resposta semelhante 
da bactéria quando exposta a ambos os produtos. As proteínas diferencialmente expressas estão relacionadas 
com: formação de pili (“type IV pilus biogenesis”) afecta a motilidade e adesão, ii) produção de vesículas da 
membrana (“putative tail sheath protein” e “bacteriophage protein”), codificadas por genes que fazem parte 
de uma ilha genómica (PAGI-6), um profago que sofreu eventos de recombinação e deleção, causando 
alterações de virulência. A diferente expressão de proteínas de tal importância, poderá estar na base da 
emergência de variantes de colónias pequenas ou mucoides em biofilmes, aumentando assim a expressão de 
factores de virulência de P. aeruginosa tais como adesão, hidrofobicidade, capacidade de locomoção e a 
capacidade de sobrevivência de biofilmes em condições de stress químico. 
Os dados obtidos ao longo deste trabalho contribuíram para a compreensão fenotípica e proteómica da 
tolerância de P. aeruginosa quando constituída em biofilme. A resistência está dependente da estirpe e em 
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estreita relação com o ambiente externo e a exposição a estes factores externos de stress poderá interferir 
com a recalcitrância da bactéria P. aeruginosa e aumento dos seus factores de virulência. 
A compreensão de tais alterações permitirá o desenvolvimento de novas e mais eficientes técnicas de 
controlo da formação de biofilme e dos procedimentos para erradicar bactérias associadas em biofilme. 
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ABBREVIATION AND ACRONYMS 
 
Abbreviation/ Acronym: term 
 
θW : Water contact angle 
θF : Formamide contact angle 
θB : α-bromonaphthalene contact angle ∆𝑮𝒊𝒘𝒊𝑻𝑶𝑻 : Free energy of interaction with water (w) ∆𝑮𝒃𝒔𝒃𝑻𝑶𝑻 : Free energy of adhesion between bacteria (b) and surface (s) 
γAB : Lifshitz-van der Waals component of the surface free energy; 
γ+ : electron acceptor parameter 
γ -- : electron donor parameter 
μg: microgram 
μL: microliter 
μm: micrometer 
 
2-D: Second dimensional gel 
2DE: Two-dimensional gel electrophoresis 
A490: Absorbance at 490 nm 
A570: Absorbance at 570 nm 
A640: Absorbance at 640 nm 
ASB 14: Amidosulfobetaine-14 
ATCC: American Type Culture Collection 
BC: Benzalkonium chloride  
BCA: Bicinchoninic acid 
cfu: Colony forming units  
CHAPS: 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate 
CHX: chlorhexidine diacetate 
CIP: Ciprofloxacin 
CV: Crystal violet  
DLVO: Theory of Derjaguin, Landau, Verwey and Overbeek 
DNA: Deoxyribonucleic acid  
E. coli: Escherichia coli 
eDNA: extracellular DNA 
EDTA: Ethylene diamine tetracetic acid 
e.g.: (exempli gratia) for example 
EPS: Extracellular polymeric substances  
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CHAPTER 1 
 
  
GENERAL INTRODUCTION  
  This chapter reviews current knowledge on P. aeruginosa virulence factors, 
particularly those related with biofilm development. Special emphasis is given on 
the sessile bacterial phenotypic response when biofilms are exposed to 
antimicrobial agents and on the proteomic characterization after stress exposure. 
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The genus Pseudomonas represents a diverse group of medically, environmentally and 
biotechnologically important bacteria. Pseudomonads are characterized by an enormous capacity 
to (i) adapt to diverse and challenging environments, (ii) degrade recalcitrant compounds and (iii) 
synthesize low-molecular-weight compounds72. 
Pseudomonas aeruginosa is a Gram-negative bacterium, nearly ubiquitous in nature and, in most 
environments, is quite innocuous. However, it can cause severe and life-threatening infections in 
cystic fibroses patients and individuals with a compromised immune system24,41,70. This bacterium 
is also able to survive in inanimate surfaces in hospitals for months48 surviving to routine cleaning 
procedures57. 
1.1 PATHOGENESIS OF PSEUDOMONAS AERUGINOSA 
Pseudomonas aeruginosa exhibits intrinsic resistance to several antimicrobial agents. This 
resistance particularly in the clinic area holds serious consequences for infection control, treatment 
regimes, and disease progression. It has been recognized that resistance towards antimicrobials can 
augment when bacteria switch from the planktonic state to the biofilm mode of life. 
Biofilms can form on abiotic surfaces, as medical implants, and during specific disease states, such 
as in the skin of burned patients and also in the lungs of cystic fibrosis patients, being extremely 
difficult to eliminate74, leading thus to increased morbidity and mortality of affected individuals. In 
healthcare environment, it is suggested that biofilms are associated with both device-related 
infections (Table 1-1) and non device-related infections (Table 1-2). Biofilms are not only a 
reservoir of pathogenic bacteria that can detach, resume their planktonic state, and spread into the 
bloodstream of the patient or colonize new surfaces, but also a source of endotoxins that may enter 
the circulation system of the patient and cause systemic disorders8. 
Table 1-1 Device-related P. aeruginosa biofilm infections 
Device Infection Ref 
Contact Lens Keratitis 26,52,61 
Inner ear Cochlear implant infection 10 
Catheter Intravascular catheter infection 49 
Prosthetic valve Endocarditis 30,73 
Peritoneal dialysis catheter Peritoneal dialysis catheter infection 80 
Prosthetic joint Prosthetic joint infection 86 
Endoscope Nosocomial outbreaks 47 
Urinary stent Urinary stent infection 34,86 
Breast implant Breast implant infection 63,86 
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Table 1-2 Non-device related P. aeruginosa biofilm infections 
Organ Infection Ref 
Skin Folliculitis wound/ulcer infections; Burn infection 64 
Ear External otitis 52,92 
Nasal Sinuses Sinusitis 12 
Urine Bladder Urinary tract infection 26,52 
Bones Diabetic osteomyelitis in feet 51 
Lungs/ bronchi 
Ventilator associated pneumonia 52 
Endo bronchiolitis; Cystic fibrosis; Bronchiectasis 26 
Blood Sepsis 52,92 
 
1.2 BACTERIAL RESISTANCE 
Bacterial resistance to antimicrobials has been reported since 1950, particularly with the 
contamination of cationic biocide formulations2,37. Biocides are used in clinical settings to control 
the growth of pathogenic microorganisms or to eliminate them from inanimate objects, surfaces or 
intact skin. The role of environmental surfaces in spreading hospital-associated infections has not 
been clearly established. Even surfaces that do not come in contact with the patients may 
contribute to epidemic or endemic spread of P. aeruginosa79,92. 
The emergence of bacterial resistance is likely to be caused by either (i) a specific modification of 
a target site or (ii) by a by-pass of a metabolic process. The efficacy of biocides depends on a 
range of intrinsic and extrinsic factors. Intrinsic factors are characteristics of the biocidal agents 
and its application. Concentration and contact time are crucial parameters being the combination 
of these factors [named C(t)] that determines the result in terms of microbial reduction. The 
concentration of a biocide is considered the most important factor that affects its efficacy77. 
Extrinsic factors derive from the environmental conditions during the biocide application, like 
temperature, pH and the presence of organic material in the environment that may reduce biocide 
efficacy18. 
There are three types of bacterial resistance to biocides: (i) intrinsic (or innate) to the 
microorganism, (ii) acquired due to the forced mutations or through the acquisition of mobile 
genetic elements, usually plasmid mediated66, and (iii) adapted resistance that results from the 
continuous exposure to a biocide81. 
The most described intrinsic resistance mechanism is the change in the permeability of the cell 
envelope or “permeability barrier”. It limits the amount of biocide that enters in the cell, thus 
decreasing the effective biocide concentration15,28. Lipopolysaccharides (LPS)57, as well as other 
outer membrane components, including proteins, fatty acids and phospholipids, account also for 
the reduced biocide efficacy. In the case of quaternary ammonium compounds (QAC), that are 
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positively charged, the charge of the cell surface also plays an important role in resistance, since it 
may annul QAC efficacy13. Another important mechanism of intrinsic resistance is the presence of 
efflux-pumps. These proteinaceous transporters localized in the cytoplasmic membrane are 
responsible for the intracellular decrease of biocide concentration and other toxic compounds87. 
The secretion of enzymes can be also responsible for bacterial resistance since enzymes can 
transform biocides making them innocuous to bacteria. This mechanism is specially reported for 
resistance mechanisms to heavy metals and parabens17. 
Concerning acquired bacterial resistance, mutation and the acquisition of resistance determinants 
are the most frequent described mechanisms75. The acquisition of resistant genes has particular 
importance as it can confer cross-resistance to other antimicrobials7,16. 
The induction of bacterial resistance mechanisms following exposure to a low concentration of a 
biocide54 involves the over-expression of efflux-pumps39,71 and the over-expression of multigene27 
and protein systems32. These mechanisms are part of the stress-response system in bacteria and 
have as consequence, for example a decrease in growth rate1, altered gene27 and protein 
expression32, and altered exopolysaccharide production29. 
Traditional antibiotic resistance usually involves inactivation of the antibiotic, modification of 
targets, and exclusion of the antibiotic25. The diverse antibiotic molecules used during 
antibiotherapy of bacterial infections may be classified according to their mechanism of action: (i) 
alteration of cell envelope (e.g.: β-lactams); (ii) inhibition of protein synthesis (e.g.: 
aminoglycosides); (iii) inhibition of nucleic acid synthesis (e.g.: quinolones) and (iv) inhibition of 
a metabolic pathway (e.g.: sulfamides). Some bacterial species are innately resistant to one class of 
antibiotics due to their envelope that limits the antibiotic penetration, or due to the presence of a 
low level of efflux-pump systems that decrease intracellular antibiotic concentration59. 
An ongoing and increasing concern is that bacteria are becoming increasingly resistant to 
antibiotics. Initially susceptible, bacteria become resistant under the selective pressure exerted by 
the misuse of antibiotics. The various antibiotic resistance mechanisms adopted by bacteria may be 
classified in: mechanical barrier (altering the required intracellular dose of antibiotic), enzymatic 
barrier (expression of a detoxifying enzyme that modifies the antibiotic), target protection barrier 
(mutation or expression of a molecule impairing the antibiotic recognition and activity)23. 
Research indicates that biocides and antibiotics may have some similar and common interactions 
and target sites with bacteria, which might express shared resistance mechanisms to both 
antimicrobials66. Biocides tend to act concurrently on multiple sites within the microorganism, and 
thus resistance is often mediated by non-specific means. Among the similarities, it can be 
mentioned: (i) the penetration/uptake through bacterial envelope by passive diffusion, (ii) the 
effect on the membrane integrity and morphology, (iii) the effect on diverse key metabolic 
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pathways. A key question is whether the indiscriminate use of biocides facilitates the selection of 
antibiotic resistant bacteria.  
1.3 PSEUDOMONAS AERUGINOSA BIOFILM FORMATION 
Biofilms have been described as structured communities of bacterial cells enclosed in a self-
produced polymeric matrix and adhered to an inert or living surface60. The development of a 
biofilm occurs via a series of well-defined stages which include: (i) translocation to the surface 
and initial and reversible adhesion of cells; (ii) irreversible attachment; (iii) microcolony 
formation; (iv) maturation and differentiation of the biofilm; and (v) dispersal of single cells or 
microcolonies from the biofilm (Fig.1-1). 
 
Fig.1-1 The biofilm life cycle (i) Translocation to the surface and initial and reversible adhesion 
of cells, (ii) Irreversible attachment, iii) Microcolony formation, (iv) Maturation and 
differentiation of the biofilm, and (v) Dispersal of single cells from the biofilm. 
Once bacteria have irreversibly attached to a surface [Fig.1-1 (ii)], as described above, the process 
of biofilm development begins. The overall density and complexity of the biofilm increases as 
surface-bound organisms begin to actively replicate and to generate extracellular components, 
giving rise to the formation of microcolonies67 [Fig.1-1 (iii)]. The bacterial biofilm maturation 
[Fig.1-1 (iv)] can be limited by the availability of nutrients in the surrounding environment, the 
perfusion of those nutrients to cells within the biofilm, and the removal of waste. Biofilms 
typically consist of differentiated mushroom- and pillar-like structures of cells embedded in the 
matrix, which are separated by water-filled channels that allow convective flows to transport 
nutrients and oxygen from the interface to the interior parts of the biofilm, and to remove 
metabolic wastes62. Cells within biofilms account just for a small fraction of the total biofilm 
volume (typically, 5–35%)25, the higher fraction being composed by the extracellular matrix that 
creates a protective environment against external threats25. 
As the biofilm reaches a critical mass, and a dynamic equilibrium is attained, some portions begin 
to detach from the biofilm and to colonize other surfaces or sites [Fig.1-1 (v)]. Biofilm 
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development, maturation, and breakdown are regulated at the level of population density-
dependent gene expression controlled by cell-to-cell signalling molecules such as acylated 
homoserine lactones4,22. The process of cell dispersion within biofilms has been termed “seeding 
dispersal” in order to differentiate it from the process of erosion, which is the passive removal of 
cells from the biofilm by fluid shear. Such process, besides involving enzymes that degrade the 
extracellular polysaccharide matrix, is also caused by death and lysis of subpopulations of cells 
within the biofilm. In P. aeruginosa biofilms, the molecular mechanisms of lysis remain to be 
fully elucidated, as symbiotic filamentous phage may play a role in cell killing within biofilms. It 
has been proposed that autolysis impacts on dispersal processes in biofilms by disrupting the 
biofilm architecture. The surviving cells in the biofilm benefit from the nutrients released by dead 
bacteria, which facilitates the conversion of surviving cells to the motile dispersal phenotype. It 
was also suggested that lysis is linked to activation of the phage of P. aeruginosa. 
As the bacterial cells adapt to growth in hydrated surface-associated biofilm communities, they 
express phenotypic traits that are often distinct from those that are expressed during planktonic 
growth83. 
1.4 PSEUDOMONAS AERUGINOSA VIRULENCE FACTORS 
This opportunistic pathogen produces a number of unique virulence factors that make it 
particularly skilled in infecting specific host tissues56. The success of P. aeruginosa lies in its 
flexible physiology, its extensive genetic regulatory networks35, ability to secret enzymes and 
exopolysaccharides, as well as in the control of the permeability of its outer membrane43,84. 
Moreover, its aptitude to move from one environment to another, as well as its capacity to adhere 
to multiple surfaces, and form biofilms are a few types of virulence factors that have been 
implicated in the pathogenicity of P. aeruginosa (Fig.1-2). These aspects of P. aeruginosa 
virulence will have a special focus in this work. 
 
Fig.1-2 Schematic diagram of P. aeruginosa virulence factors 
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1.4.1 Motility 
Motility is one of the most remarkable features of P. aeruginosa life on surfaces. Its roles include 
increased efficiency of nutrient uptake, evasion of toxic substances, ability to translocate to 
preferred hosts and to access to optimal colonization sites within them, as well as dispersal in the 
environment46. Bacterial movement has been classified into different types: Swimming is a 
flagellum-mediated type of motility that allows bacteria to move on liquid surfaces; Swarming 
motility is operationally defined as a rapid multicellular movement of bacteria across a surface, 
powered by rotating flagella46; and Twitching is a surface motility powered by the extension and 
retraction of type IV pili, which confers slow cell movement46. 
Motility is central in the biofilm development process since planktonic cells use this trait to make 
the initial contacts with a surface, and to spread across the surface20. Before attachment P. 
aeruginosa swims along the surface almost like scanning for an appropriate location for initial 
contact60. Flagella-mediated motility is also essential to bring the cell within close proximity of the 
surface and to overcome repulsive forces between bacterium and the surface. Type IV pili are 
responsible for a form of surface-associated movement known as twitching motility that plays an 
important role in bacterial adhesion68. Furthermore, there are indications that cells move by 
twitching motility only when they are in contact with other cells, suggesting that this is a social 
network behaviour60. Flagella-mediated motility is important for the formation of a bacterial 
monolayer on the surfaces, whereas type IV pili appear to play a role in subsequent microcolony 
formation62. In the early stages of adhesion, microcolonies can also disperse and/or move as a unit 
across a surface, further emphasizing the dynamic and somewhat transient early interactions of 
bacteria with a surface and with each other60. 
1.4.2 Bacterial Adhesion 
Adhesion of bacteria to human cells and surfaces of medical devices is an important step in the 
pathogenesis of infection9. The process of microbial adhesion to surfaces is largely dictated by a 
number of variables, including the species of bacteria, cell surface composition, nature and coating 
of surfaces, nutrient availability, hydrodynamics and cell-to-cell communication33. 
In its basic form, bacterial adhesion can be divided into two stages: the primary or docking stage 
and the secondary or locking phase9,33. An additional step in the adhesion process, surface 
conditioning, can be added to describe the interaction of the substratum with its environment9,42. 
Conditioning can occur mainly by: i) the deplored practice of “topping-up” of biocide solutions 
without subsequent washing with water; ii) the incorrect use of biocides and incorrect 
concentrations used; iii) the use of a biocide that is not appropriate for a certain type of surface; iv) 
pre-cleaning errors, for example, residue deposition of several products that can interfere with the 
activity of each other76,82. Once a surface has been conditioned, its properties become permanently 
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altered, so the affinity of an organism for a clean or a conditioned surface can vary greatly 
depending on the molecules in the conditioning film40,58.  
The primary adhesion between bacteria and surfaces is reversible and is controlled by a number of 
physicochemical variables that define the interaction between the bacterial cell surface and the 
adhesion surface55. First, the organism must be brought into close proximity of the surface, either 
randomly by a stream of fluid or via chemotaxis and motility. Once the organism reaches critical 
proximity to the surface the final determination of adhesion depends on the net sum of attractive or 
repulsive forces generated between the two entities. These forces include electrostatic and 
hydrophobic interactions, van der Waals forces, temperature, and hydrodynamic forces14. The 
second stage of adhesion is the anchoring or locking phase and employs molecularly mediated 
binding between specific adhesins and the surface. At this point, loosely bound organisms 
strengthen the adhesion process by producing exopolysaccharides and/or receptor-specific ligands 
located on pili, fimbriae, and fibrillae, or both. At the end of the second stage, adhesion becomes 
irreversible in the absence of physical or chemical intervention, and the organism is attached 
firmly to the surface9. 
1.4.3 Biofilm resistance 
Bacteria that attach to a surface and grow as a biofilm are protected from killing by host defences 
and antimicrobial agents. This type of resistance unique to biofilm-associated bacteria and distinct 
from conventional antimicrobial resistance, holds serious consequences for therapy of infections 
involving biofilms74. The resistance that bacteria exhibit when growing in biofilms is not only due 
to ‘‘classic’’ genetic mechanisms but is also determined by some particularities of biofilm growth. 
A variety of potential mechanisms implicated in biofilm resistance are shown in Fig.1-3 21,33,44. 
Some of the referred biofilm resistance mechanisms will be described with more detail, due to 
their importance in the overall results presented in this work. 
 
Fig.1-3 Mechanisms implicated in biofilm resistance to antimicrobial agents 
(adapted from Harrison et al.44). 
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Biofilm tolerance to antimicrobial products and antibiotics may result from: (i) slow microbial 
growth rates that are attributable to nutrient and oxygen depletion within biofilms; (ii) intercellular 
signals that can alter the physiology of the biofilm, causing members to produce molecular pumps 
that expel antibiotics from the cells and allow the community to tolerate the presence of the drug; 
(iii) the diffusion barrier promoted by the biofilm matrix that prevents antimicrobial products to 
reach their targets, being also responsible of the neutralization or degradation of the antimicrobial 
or antibiotic due to charge difference; (iv) the specialized populations of persister cells, that do not 
grow in the presence of an antibiotic, but neither do they die, so when the drug is removed, 
persisters can give rise to a normal bacterial colony; (v) population physiological and genetic 
diversity, that act as an "insurance policy", that improves the chance of surviving of some cells.  
Proteins involved in oxidative stress response, cell envelope synthesis, and EPS synthesis are up-
regulated in biofilm-cells, indicating that these altered phenotypes might contribute to cell 
survival, persistence, and growth in a biofilm community. Moreover, biofilms can comprise more 
than one strain. Besides the ecological advantages, this trait can promote genetic changes during 
biofilm development, increasing species interactions83, and also the chance for interspecies gene 
transfer and the consequent spread of virulence factors and antibiotic resistance90.  
According to Flemming and Wingender36, in most biofilms, the microorganisms account for less 
than 10% of the dry mass, whereas the matrix can account for over 90% providing a complex 
microenvironment surrounding the biofilm-attached microorganisms3 [Fig.1-3 (iii)]. Thus, matrix 
composition plays significant importance in the biofilm mode of life, acting as a “filter” to the 
chemical diffusion and the gradient of oxygen and nutrients to the cells, and managing also the 
outflowing of bacterial metabolites. One of the most important P. aeruginosa biofilm features is 
the production of extracellular polymeric substances (EPS) that makes up the matrix38,91. The EPS 
are mainly composed of alginate. Some biochemical studies revealed another two distinct 
carbohydrate-rich polymers that make significant contributions to P. aeruginosa biofilm structure: 
a glucose-rich polymer (PEL), and a mannose-rich polymer (PSL)11,38. Moreover, matrix also 
contains, in less amount, proteins, and nucleic acids78 and a variety of cell appendages that, 
together with EPS, confer biofilms their structure but also the ideal surrounding to protect biofilm-
entrapped cells and to establish changes with the environment. 
Bacteria that grow within biofilms express phenotypic traits that are often distinct from those that 
are expressed during planktonic growth [Fig.1-3 (v)]. Physiological adaptation that bacteria 
experience following attachment and growth on surfaces include the production of extracellular 
organelles, such as pili and flagella, altered polysaccharide production and even cell morphology83. 
The environmental conditions to which biofilms are exposed or the metabolic activities of bacteria 
within biofilms result in microscale heterogeneities in the chemical and physical parameters of the 
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biofilm, resulting in unique environmental niches that confer biofilm-entrapped cells 
heterogeneity31.  
Although adaptation to the local environment explain much of the biological heterogeneity in 
biofilms, it is likely that other mechanisms also contribute to the phenotypic differentiation83. 
Mutation or recombination of the original population as well as stochastic gene expression and 
changes at specific genetic loci might also generate genetic variants in biofilms. These variants 
have been detected primarily as changes in the colony morphology of subpopulations of cells. 
Examples of differences observed in colony morphology include the small rough or wrinkly 
variants of P. aeruginosa. These biofilm variants hyperexpress psl and pel two of the previously 
referred EPS gene clusters secreted by P. aeruginosa83. It has been proposed that genetic change 
and diversification of bacteria within a biofilm community act as an insurance policy against 
antimicrobial challenges or environmental changes, with the diversified population being more 
robust than a single parent strain. Some studies have also suggested that phenotypic variation also 
generates cells more able to adhere to surfaces53. 
According to del Pozo et al.25, biofilm antimicrobial treatment may act as selector of phenotypic 
traits, leading to the eradication of most of the susceptible population. As antimicrobial agents 
target rapidly growing cells, the small fraction of slow or non-growing bacteria [Fig.1-3 (i)] may 
differentiate into a protected phenotypic state. These cells referred as persisters [Fig.1-3 (iv)], are 
present in the deep layers of biofilms, surviving the antimicrobial action and being able to 
reconstitute the biofilm following the environmental pressure release by the antimicrobial therapy. 
These phenomena may explain in part, the resistance of bacterial biofilms to certain types of 
antimicrobials. 
 
1.5 PROTEOMIC APPROACH TO STUDY BIOFILMS 
The term proteome was first used to identify the set of proteins encoded by the genome of 
Mycoplasma genitalium88. The study of proteome referred as Proteomics is now used to describe 
not only the proteins of any given cell, but also the set of all protein isoforms and modifications 
and the interaction between them5. 
The field of proteomics evolved rapidly during the last two decades due to the development of 
mass spectrometry techniques and also to the complete genome sequences of many 
microorganisms. Two-dimensional electrophoresis (2-DE) followed by image analysis allows the 
comparison of thousands of proteins from bacteria. Spot excision and subsequent peptide mass 
fingerprinting allows, in most cases, to positively identify proteins of interest and thus to perform 
studies to investigate protein expression change between bacteria growing in different conditions, 
different strains, treated or exposed to chemicals including antimicrobial drugs50. 2-DE has 
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significant advantages when compared with 1D as it provides high-resolution protein separation 
and for the downstream identification of the observed protein markers. 
Many important fundamental studies on P. aeruginosa biofilms were performed with this gel-
based technique, especially those related with the differences observed between planktonic and 
biofilm mode of growth19,85.  During some stages of biofilm development, as much as 50% of the 
proteome can be differentially produced compared with the same cells growing in planktonic 
culture65. 
Microorganisms within the biofilms can also respond differently to environmental conditions 
when compared with planktonic counterparts, including: altering gene-expression patterns or 
physiological activities to adapt to a particular location within the biofilm; enriching for 
populations of a particular phenotype that are best adapted to a particular condition; and selecting 
for fitter mutant strains that can better survive under a given condition. Natural variants within 
biofilm subpopulations can also increase fitness by providing tolerance to antimicrobial challenges 
and resilience to changing environmental conditions83. 
Proteomic characterization of membrane proteins is of extreme importance, since proteins of this 
sub-cellular location are part of the interface between the outside and the inside of the cell. As 
such, they are implicated in key cellular functions such as small molecules transport, cell-cell 
and/or cell-pathogen and/or cell substrate recognition and interaction, cell communication and 
signalling, with all the possible modifications in cell functionality that can arise subsequently to 
the activity of these membrane proteins69. 
 
Bacteria are able to adapt to environmental stresses such as the presence of antimicrobial 
molecules and, as consequence, resistance may increase with increasing exposure to 
antimicrobials45. One of the most impressive mechanisms of bacterial adaptation is growth as part 
of a biofilm community. Biofilm formation is an important aspect, in bacterial diseases, especially 
in those device-related. When biofilms are identified as the cause of disease, treatment becomes 
tremendously difficult since bacteria within the biofilm demonstrate important features, being the 
adaptive response to antimicrobial stresses more effective than the corresponding planktonic 
populations21. P. aeruginosa is frequently studied because it is one of the major bacteria that cause 
hospital outbreaks89 and exhibits notorious tolerance to antimicrobial agents, namely in the sessile 
mode of growth. Although some of the P. aeruginosa virulence factors have been well described 
and characterized, there is a scarce knowledge regarding phenotypic traits of biofilms after biocide 
pressure, as well as the possible link to cross-resistance to antibiotics. Emerging bacterial 
resistance against different types of antimicrobials lead to concerns regarding their prudent use, the 
correct definition of cleaning procedures in all areas and the identification of the major 
contributors to resistance. Moreover, it is also very important to understand how the selection and 
General Introduction Chapter 1 
 
 39 
the dissemination of biocide resistant pathogens occurs in real scenarios in order to develop new 
ways to control the increase of healthcare associated diseases6. The characterization of the biofilm 
population concerning its phenotypic switching, as well as the proteomic changes undergone after 
antimicrobial exposure, is of upmost importance, since little is known about this type of bacterial 
response. 
Thus, this work aimed to bring insights into P. aeruginosa biofilms focusing on the interplay of 
different virulence factors, especially with regard to the role of motility in P. aeruginosa biofilm 
formation (Chapter 3.1), persister cell selection (Chapter 3.2) as well as the bacterial adaptive 
resistance to antimicrobials (Chapter 4), and the proteome characterization of P. aeruginosa after 
stress exposure (Chapter 5).  
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METHODOLOGY  
  The methods and techniques used in the present work are described in this 
Chapter. The rationale beyond its employment is also discussed. 
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2.1 MICROORGANISMS AND CULTURE CONDITIONS 
2.1.1 Microorganisms 
Different Pseudomonas aeruginosa strains were used throughout this work: 
- The type strain purchased from the American Type Culture Collection, Pseudomonas aeruginosa 
ATCC 10145. 
- Pseudomonas aeruginosa surface isolated from a biofilm formed in a medical device 
(gastrointestinal endoscope) in a Hospital in France, this strain was kindly provided by Thierry 
Jouenne from University of Rouen, France.  
- P. aeruginosa clinical isolated strains, I93488, I92986, I97824, C80117, U147016, these strains 
were kindly provided by Dra. Alberta Faustino from S. Marcos Hospital in Braga. 
- The type strain Escherichia coli K12 substrain MG 1655, kindly provided by Rafael Costa from 
Centre of Biological Engineering of the University of Minho. 
2.1.2 Bacteria preservation 
Bacteria were preserved at – 80 ± 2˚C in 10% glycerol stocks. Prior to each experiment, bacterial 
cells were grown on Tryptic Soy Agar (TSA, Merck) plates for 24 h, at 37˚C. 
2.1.3 Culture medium 
To prepare the bacterial suspensions, one colony of each bacterium was collected from the TSA 
plates and grown in Tryptic Soy Broth (TSB, autoclaved at 121ºC for 20 min) for 24 h at 37°C, in 
a horizontal shaker (120 rpm). Subsequently, bacteria were washed twice with ultrapure sterilized 
water (UP). Standardized cell suspensions were prepared in TSB at a cell density of 1 × 107 
cfu/mL, unless otherwise stated. 
2.1.4 Antibacterial and antibiotic agents 
Benzalkonium chloride (BC), a quaternary ammonium compound, widely used in clinical 
disinfectant formulations, was purchased from Calbiochem (Merck Biosciences). 
Ciprofloxacin (CIP), a broad-spectrum antimicrobial from the fluoroquinolone drug class and 
Gentamicin (GM), an aminoglycoside, were purchased from Fluka. Both antibiotics are used 
clinically to treat chronic P. aeruginosa infections.  
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2.2 PLANKTONIC STUDIES 
2.2.1 Determination of minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) 
The MIC and MBC of BC of P. aeruginosa and E. coli were determined by the microdilution 
method according to Clinical and Laboratory Standards Institute (formerly NCCLS)11. 
Briefly, 96-well round-bottom polystyrene (PS) microtiter plates (Orange) with a total well 
capacity of 300 μL were used. In each well, 50 μL of fresh TSB with increasing concentrations of 
BC were added to 50 μL of each bacterial inoculum (containing 1 x 105 cfu/mL). The culture-
plates were incubated at 37˚C for 24 h in an orbital shaker at 120 rpm. The highest concentration 
of BC that did not promote growth was recorded as the MIC. 
MBC determination was performed by transferring 10 μL of culture from each well without visible 
growth into TSA plates. The lowest antimicrobial concentration that yielded no colony growth 
after 24 h at 37°C was documented as the MBC. 
2.2.2 Development of planktonic bacteria adaptive resistance 
BC adaptive resistance was induced in P. aeruginosa ATCC 10145 to further evaluate the role of 
this feature on cell surface physicochemical properties, early adhesion and biofilm formation 
ability. 
Adaptive resistance was induced by subculturing P. aeruginosa in TSB supplemented with 
increasing concentrations of BC, based on the adaptive procedures described by Mangalappalli-
Illathu and Korber8 and Loughlin et al.7 (Fig.2-1). Five millilitres of an overnight culture (1 x 107 
cfu/mL) were added to flasks containing 45 mL of TSB supplemented with BC at the final 
concentrations of 0.5, 0.9, 1.3 and 2.0 mM. Cultures were then incubated at 37ºC for 48 h on a 
horizontal shaker (120 rpm). Bacterial growth was monitored by optical density measurement at 
640 nm (OD640). Every two days, 5 mL of the bacterial culture, supplemented with the highest BC 
concentration that showed growth, were used to inoculate 45 mL of TSB containing BC in a final 
concentration 0.2 mM higher than the one that exhibited growth. At the end of the third growth 
cycle in increased BC solutions, no significant bacterial load was observed. Bacteria were then 
subcultured in the presence of the maximum BC concentration that allowed growth for another 
three complete cycles. At the end of the adaptation process, the purity of the cultures was checked 
by spreading aliquots on to Pseudomonas spp. selective agar (Cetrimide agar base, DIFCO). 
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Fig.2-1 Summary scheme of the adaptation process. 0.5 to 12.0 mM refers to benzalkonium 
chloride concentration (mM); ODi and ODf are respectively the growth of bacteria observed by 
absorbance reading at 640 nm (OD640) in the beginning and the end of each stage of adaptation. 
n.g. represents planktonic culture where no growth was observed. 
The stability of the BC-adapted strain was later determined by continuous subculture every 24 h 
for 10 passages in TSA and subsequent evaluation of the adapted strain ability to maintain their 
growth in TSA supplemented with BC. To preserve the BC-adapted strains, petri dishes were 
prepared with TSA supplemented with BC at a final concentration of 0.9 mM, 4.0 mM and 
12.0 mM. Bacteria from the step-wise training were preserved in the TSA supplemented with BC, 
being the plates incubated at 37ºC for 24 h.  
2.2.3 Determination of the bacterial growth kinetics 
In order to determine the potential adaptive resistance of the BC-adapted P. aeruginosa was 
checked by bacterial growth in the presence of increasing concentrations of BC.  
Microtiter polystyrene (PS) 96-well round tissue culture plate (Orange) containing 100 μL of TSB 
supplemented with BC in a range of concentrations from 0.3 to 3.0 mM, were inoculated with 
100 μL of P. aeruginosa ATCC 10145 and BC-adapted P. aeruginosa aliquots, prepared by 
adjusting overnight cultures to 1 x 107 cfu/mL in TSB. Plates were incubated aerobically at 37ºC 
on a horizontal shaker (120 rpm). Each plate included positive control wells comprising 100 μL of 
TSB and 100 μL of each strain aliquots. Negative controls were also performed comprising 
100 μL of BC solution at each concentration tested, and 100 μL of TSB. 
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The OD640 of each well content was recorded using an automated plate reader (Bio-Tek Synergy 
HT, Isaza) as a measure of bacterial growth. The average OD640 and the standard deviation from 
eight different wells were determined for each time point and each condition tested. This 
experiment was performed in three independent assays. 
2.2.4 Bacterial motility assessment 
To evaluate the motility ability of each bacterial strain, swimming, swarming and twitching assays 
were performed. Bacteria were inoculated with a needle into the bottom of Luria Broth (LB) agar 
medium (1.5, 0.3 or 0.6% agar for, respectively, twitching, swimming or swarming tests, average 
inoculation depth of 3 mm). Plates were incubated at 37ºC for 24 h and for each P. aeruginosa 
strain, five colonies were examined regarding the diameter of the migration zone as well as the 
border shape. Images were taken on an Olympus SZ 40 stereo microscope (Olympus, Tokyo). All 
the images were digitized and saved using a CCD AVC D5CE Sony grey scale video camera 
(Sony, Tokyo) and a DT 3155 Data Translation frame grabber (Data Translation, Marlboro) with 
768 x 576 pixel size in 8 bits (256 grey levels) by Image Pro Plus (Media Cybernetics, Silver 
Spring, MD) software package. 
 
2.3 ADHESION ASSAYS 
2.3.1 Surfaces conditioning 
In order to examine the effect of BC residues in the thermodynamic prediction of adhesion, early 
bacterial adhesion and biofilm formation, several PS surfaces of different sizes, depending on the 
type of experience, were previously conditioned through random deposition of BC residues. 
Prior to surface conditioning, the coupons and the adhesion plates were cleaned by 50% maximum 
amplitude sonication using an ultrasonic processor (Cole-Parmer Instruments), for 3 min, in a 
commercial detergent solution (Sonasol Pril, Henkel Ibérica S. A.). Coupons and plates were 
rinsed with UP sterilized water, subsequently immersed in ethanol at 96% (v/v) for 10 s and then 
rinsed three times with UP sterilized water. For conditioning purposes, coupons or plates were left 
in contact with a 0.9 mM BC solution for 1 h. Non-conditioned surfaces were achieved by the 
contact of the surfaces with UP sterilized water, for the same period of time.  
For biofilm studies, microtiter plates of 96-wells, with flat and clear bottoms, were conditioned by 
filing the wells with 200 μL of a 0.9 mM BC solution for 1 h. Wells filled with 200 μL of UP 
sterilized water were considered non-conditioned wells or clean surfaces. 
All the conditioned and non-conditioned surfaces were air dried at room temperature for 30 min 
before being used in each experience. 
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2.3.2 Physicochemical characterization of surfaces and cells 
Several studies dealing with relations between physicochemical surface properties of bacterial 
cells and substrata have been reported in the literature9. These studies are of great significance, 
since thermodynamic properties play a key role in the initial bacterial adhesion to surfaces3. In 
order to investigate the physicochemical properties of P. aeruginosa reference strain, and BC-
adapted cells and PS surface, the contact angles (Fig.2-2) and hydrophobicity were determined for 
both bacteria and clean and BC-conditioned surfaces, following the van Oss et al. approach17.  
 
Fig.2-2 Schematic diagram of the relation between the surface contact 
angle and wetting of the surface (adapted from http://pixes.eu and 
http://www.harrickplasma.com (March, 2011)). 
The free energy of interaction was calculated through the surface tension parameters of the 
interacting entities, according to: 
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where γAB accounts for the Lifshitz-van der Waals component of the surface free energy and γ+ 
and γ- are the electron acceptor and electron donor parameters. 
Bacterial cells were grown in TSB at 37°C under agitation (120 rpm) until reaching the stationary 
phase of growth. Cells were harvested by centrifugation (5 000 x g for 10 min, at 4°C), washed 
three times in UP sterilized water and resuspended in 200 mL of UP water in order to achieve the 
bacterial concentration of 1 x 109 cfu/mL. To obtain a thick lawn of cells, a volume of 20 mL of 
the cell suspension was filtered through a 0.45 μm cellulose membrane filter, previously washed 
with 10 mL of sterile distilled water. The lawn of cells was then air-dried for at least 3.5 h, until 
the so-call “dried-plateau” was obtained. 
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The surface tension of strains and materials was determined using the sessile drop contact angle 
method. Contact angles were standardized using as reference liquids: water, formamide and α-
bromonaphthalene (Sigma). The determination of contact angles was performed automatically 
using a model OCA 15 Plus (Dataphisics) video based optical contact angle measure instrument 
that allows image acquisition and data analysis. At least 25 determinations for each liquid and for 
each bacteria and material were performed. This experiment was repeated in three different assays. 
2.3.3 Parallel Plate Flow Chamber (PPFC) 
A parallel plate flow chamber (PPFC) (Fig.2-3) and image analysis system were employed to 
study early-stage bacterial adhesion and detachment, as described by Sjollema et al.13. The PPFC 
consists of a nickel-coated frame measuring 16 x 8 x 1.8 cm. Teflon spacers were placed between 
the PS plates, to separate them by 0.06 cm [Fig.2-3 (a)]. 
 
Fig.2-3 Representative scheme of the parallel plate flow chamber system (adapted from Azeredo et al. 1) 
The PFFC device was mounted in a phase contrast inverted microscope (Diaphot 300; Nikon) 
equipped with a 40 x ultra long working distance objective [Fig.2-3 (b)]. The images were 
acquired in a CCD camera (AVC, D5CE; Sony, Japan) connected to the microscope and coupled 
to an image analyser (Image Proplus 4.5; Media Cybernetics).  
Prior to each experiment, all tubes and the flow chamber were filled with sterile PBS, taking care 
to remove air bubbles from the system. To assess the rate of wild-type and BC-adapted P. 
aeruginosa attachment to clean and BC-conditioned PS surfaces, bacterial suspensions were 
circulated through the PPFC at 0.020 mL/s for 30 min. Then, PBS was circulated at the same flow 
through the equipment to remove unattached and weakly adhering cells, thus allowing the 
evaluation of the bacterial cells detachment. 
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2.4 BIOFILMS 
2.4.1 Biofilm Formation 
2.4.1.1 Biofilm inoculum 
For biofilm formation, cells within the bacterial suspension were harvested by centrifugation and 
washed twice with ultrapure (UP) sterilized water. Standardized cell suspensions were prepared in 
TSB at a cell density of 1 x 107 cfu/mL. In order to develop mixed species biofilms, 50% of cell 
suspensions of each bacterium were used. 
2.4.1.2 High-throughput devices 
Tissue culture plates with flat bottoms, of 6, 24 and 96 wells were used throughout this work. 
These high-throughput devices allow the formation of high number of biofilms with similar 
characteristics, making them the ideal surfaces to test antimicrobial products effects in mature 
biofilms. 
2.4.1.3 Biofilm Development 
The methodology used to grow the bacterial biofilms was based on the microtiter plate test 
developed by Stepanovic et al.15. Two hundred microliters per well of cell suspensions were 
transferred to sterile 96-well flat-bottom tissue culture plates (Orange). All the plates were 
incubated aerobically on a horizontal shaker (120 rpm), at 37˚C. 
2.4.2 Biofilm adaptation 
To induce the adaptation of the biofilm-embedded cells, biofilms were developed for 24 h in 96-
well flat-bottom tissue culture plates. For biofilm adaptation, the wells were re-filed with fresh 
TSB or TSB containing BC in a final concentration of 0.9 mM. The process of supernatant 
removal and media filling was repeated for five subsequent days, every 24 h.  
For proteomics studies, biofilms were developed during 24 h in TSB in 6-well flat-bottom tissue 
culture plates being after adapted to 0.9 mM (320 mg/L) of BC or 6.0 mg/L of CIP during 12 days. 
2.4.3 Biofilm Treatment 
After being developed, biofilms were subjected subsequently to treatment with the same 
antimicrobial product. For that, the content of each well was removed and washed once with 
200 μL of UP sterilized water, being the well-attached biofilms subsequently treated with 200 μL 
of 1.0 mM of BC for 30 min. The BC concentration was similar to the one used for biofilm 
adaptation due to the fact that the concentration of 0.9 mM is already a high concentration when 
compared with the normally in-use BC concentration in cleaning products [1.0% (w/v)]6. This 
procedure had the major purpose of eliminating more susceptible and outward biofilm-cells. Non-
treated wells were filled with 200 μL of UP sterilized water for the same period of time. After that, 
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the content of each well was removed and biofilms were washed twice with 200 μL with UP 
sterilized water and reserved for subsequent analysis. 
2.4.4 Biofilm analyses methods 
2.4.4.1 Scanning electron microscopy (SEM) observations  
Prior to SEM observations, the wells-attached washed biofilms were gradually dehydrated in an 
absolute ethanol (Merck) series (15 min each in 10, 25, 40, 50, 70, 80, 90 and 100% v/v). The 
biofilms were kept in a dessicator until the walls of the wells were cut and coated with gold. The 
examination of the surface structural conformation of the biofilms was performed with a Leo 
scanning electron microscope (Cambridge). SEM observations were documented through the 
acquisition of representative microphotographs. 
2.4.4.2 Biofilm mass 
Biofilm biomass was quantified by crystal violet (CV) staining method adapted from Stepanovic et 
al.15. For that, the plates containing the washed biofilms were left to air dry for 30 min, and 200 μL 
of 98% methanol were transferred to each well in order to fix the remaining attached bacteria, for 
15 min. Afterwards, the plates were emptied and left to air dry again. The fixed bacteria were 
stained with 200 μL of 1% (w/v) CV (Gram colour-staining; Merck) per well, for 5 min. After the 
staining step, the plates were washed with running tap water and air dried for approximately 
20 min and, at last, 200 μL of 33% (v/v) of acetic acid (Merck) were added to each well in order to 
solubilise the CV bound to the adherent bacteria. The quantitative analysis of biofilm production 
was performed through the measurement of optical density at 570 nm (OD570) in each well using a 
microtiter plate reader, being the biofilm mass presented as OD570. Control experiments to avoid 
false results were also performed in order to determine whether the tested media and the plate 
material could adsorb CV and interfere with biomass quantification. When the optical density was 
higher than 1.0 the sample was diluted with 33% (v/v) of acetic acid. For each condition tested, 16 
different wells were used to perform biofilm analysis and the experiment was repeated in three 
independent assays. 
2.4.4.3 Biofilm activity 
Biofilm activity determination was evaluated with 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide sodium salt (XTT) colorimetric method as described by Stevens and 
Olsen16, with some modifications. 
Bacteria, when metabolically active, reduce XTT to a water-soluble orange formazan that diffuses 
from the cells and thus does not require solvent extract prior to its quantification. Since the 
formazan product is water soluble, it is easily quantified by spectrophotometry analysis. Therefore, 
the quantity of formazan produced is used as a measure of the total respiratory activity of the 
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bacteria. This latter point is important in biofilm research because the XTT assay allows the study 
of intact biofilms without disruption biofilm structure5. 
After biofilm growth and washing procedures, 200 μL of a combined solution of XTT (Sigma) and 
phenazine methosulfate (PMS) (Sigma) were added to each well in order to obtain a final 
concentration of 150 mg/L of XTT and 10 mg/L of PMS. After that, plates were incubated at 37°C 
for 3 h, at 120 rpm, in the dark. Biofilm activity was determined through the measurement of the 
optical density at 490 nm (OD490) in each well using a microtiter plate reader, being biofilm 
activity presented as OD490. Control tests, using culture medium and empty wells, were also 
carried out in order to avoid misleading results. For each condition tested, 16 different wells were 
used to perform biofilm analysis and the experiment was repeated in three independent assays. 
2.4.4.4 Biofilm entrapped cells 
Bacterial suspensions of the biofilms to be used in cfu determination and also in protein and 
polysaccharide quantification were prepared as described hereafter. Two hundred microliters of 
UP sterilized water were added to each well, being the wells-attached washed biofilms removed by 
ultrasonic bath in a Sonicor SC-52 (Sonicor Instruments) operating at 50 kHz, during 6 min (these 
parameters were previously optimized in order to promote the complete removal of all the biofilm-
attached cells without lysis). Afterwards, bacterial suspensions of each 5 wells per condition were 
collected, gently vortexed for 2 min to disrupt possible cell aggregates, and reserved for later 
analysis. 
In order to determine the number of cfu, biofilm suspensions removed by sonication were serially 
diluted. After plating the serial dilution on TSA, plates were incubated at 37°C for 24 h prior to 
enumeration. 
2.4.4.5 Proteins and Polysaccharides Content 
The total biofilm content of proteins of biofilms was determined using the BCA Protein Assay Kit 
(Pierce), with bovine serum albumin as a protein standard, and the optical density (OD) values 
recorded at 740 nm. The total polysaccharides content was determined by the phenol-sulphuric 
acid method described by Dubois et al.4 with glucose as standard, and the OD values were 
recorded at 490 nm. This biochemical characterization was performed in three independent 
experiments. 
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2.5 PROTEOMICS 
2.5.1 Preparation and analysis of planktonic outer membrane protein (OMP) extracts 
For planktonic proteomic studies, crude outer membrane extracts were prepared from bacterial 
pellets following the spheroplast procedure described by Mizuno and Kageyama10. 
For protein extraction, standardized cell suspensions were prepared in a minimal salt medium 
(MSM medium, pH 7.5)19. The bacterial cell concentration of each suspension was estimated by 
OD640 referred to a calibration curve2. The bacterial planktonic cultures were prepared in 800 mL 
of MSM medium by adjusting the final cell concentration to 1 x 107 cfu/mL and were let to grow at 
37°C for 20 h, at 150 rpm. Bacterial cultures were harvested for 15 min at 3 500 x g and washed 
twice with 20% (w/v) sucrose solution. Cells were suspended in a digestion solution with the 
following composition: 9 mL 2.0 M sucrose solution; 10 mL 0.1 M Tris-HCl pH 7.8, at 25 °C; 0.8 
mL 1% (w/v) Na-EDTA, pH 7.0; 1.8 mL 0.5% (w/v) lysozime. The mixture was incubated for 1.5 
h at 37ºC in the presence of DNAse and RNAse (5 mg/L; Sigma). Spheroplasts were collected by 
centrifugation (20 min at 10 000 x g) and outer membranes were then pelleted (120 000 x g for 1 h 
at 4°C) and resuspended in 1 mL of sterile UP water. The protein amount was measured using the 
Bio-Rad protein assay (Bio-Rad, Hercules, CA). 
2.5.2 Preparation and analysis of biofilm-entrapped cells outer membrane protein (OMP) extracts 
For biofilm proteome analyses, OMP from biofilm-entrapped cells and matrix proteins were 
extracted.  Bacterial cultures were harvested for 15 min at 3500 x g and cells were suspended in 
one millilitre of CHAPS. Cells were then disrupted by sonication (Ultrasonic Processor, Cole-
Parmer, USA) using 10 W power for 6 x 10 s on ice. Unbroken cells and cell debris were removed 
from the resulting suspension by centrifugation at 7 000 x g for 10 min at 4°C. The supernatant 
was then centrifuged at 100 000 x g for 1 h at 4°C, the formed pellet representing the total 
membrane fraction. The separation of the bacterial membranes was adapted from that described by 
Winder et al.20. Membrane proteins were incubated in 25 mL of 2% (w/v) sodium lauryl 
sarcosinate solution at room temperature for 1 h, followed by centrifugation at 100 000 x g for 1 h 
at 4°C. The resulting pellet, which represents the outer membrane fraction, was resuspended in one 
millilitre of UP water. The protein amount was measured using the Bio-Rad protein assay (Bio-
Rad, Hercules, CA). 
2.5.3 Two-dimensional gel electrophoresis 
Outer Membrane Protein patterns were analysed by two-dimensional gel electrophoresis (2-DE). 
Two hundred micrograms of proteins were added to isoelectric focusing (IEF) buffer (final 
volume, 300 μL)18. The first-dimension gel separation was carried out with Immobiline Dry Strips 
L (pH 4–7, Amersham Pharmacia Biotech). The second dimension was obtained by SDS–PAGE 
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using a 12.5% (w/v) polyacrylamide resolving gel (width 16 cm, length 20 cm, thickness 0.75 
mm). After migration, proteins were visualized by silver nitrate staining12. 
2.5.4 Gel analysis 
Spot quantification was achieved by computing scanning densitometry (ProXPRESS 2D, 
PerkinElmer Sciex). Gels were analysed using the Progenesis Samespot (Nonlinear Dynamics) 
software. For each experimental condition, three 2-DE gels were matched together to form a 
reference image. The two reference gels were then matched together so that the same spot in 
different gels had the same number. Protein spots from the two bacterial populations were 
considered to display significant quantitative differences if they fulfilled the following criteria: p 
values ≤ 0.05 (t-test); detection threshold, average volume ≥ 20 (n = 3); differential tolerance, fold 
change ≥ 214. It was also considered the q value (q ≤ 0.05) to guarantee that no false positives were 
erroneously analysed. 
2.5.5 Protein identification 
Spots were excised from the polyacrylamide gel and sliced into small pieces with an automatic 
spot cutter (ProXCISION). Selected spots complied with the following criteria: volume varying 
with the incubation condition and displaying a high (average) value with a low coefficient of 
variation. Gel plugs were then dried using a SpeedVac centrifuge. Trypsin digestion was 
performed using an automatic digester (MultiPROBE II, PerkinElmer Sciex). After lyophilisation, 
the peptide extracts were resuspended in 10 μL of 0.2% formic acid/5% acetonitrile. 
Peptides were enriched and separated using a lab-on-a-chip technology (Agilent) and fragmented 
using an on-line XCT mass spectrometer (Agilent). The fragmentation data were interpreted using 
the Data Analysis program (version 3.4, Bruker Daltonic).  
2.5.6 Bioinformatic tools for subcellular location 
For protein identification, MS/MS peak lists were extracted and compared to the NCBInr protein 
database restricted to P. aeruginosa (February 2, 2007, version 4, 1,342,017 residues, 4243 
sequences), using the MASCOT Daemon (version 2.1.3) search engine. All searches were 
performed with no fixed modification and allowed for carbamidomethylation, oxidation and a 
maximum of one missed trypsin cleavage. MS/MS spectra were searched with a mass tolerance of 
1.6 Da for precursor ions and 0.8 Da for fragment ions, respectively. If a protein was characterized 
by 2 peptides with a fragmentation profile score higher than 25 the protein was validated. When 
one of the criteria was not met, peptides were systematically checked and/or interpreted manually 
to confirm or cancel the MASCOT suggestion. 
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For identified proteins, and in particular for unknown proteins, the prediction of their location 
within the bacterial cell was obtained from the genome annotation of P. aeruginosa (accessible at 
http://www.pseudomonas.com/). 
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MOTILITY, BIOFILM FORMING ABILITY AND TOLERANCE DEVELOPMENT OF 
PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES  
Pseudomonas aeruginosa is an opportunistic pathogen, widely investigated for its high incidence in clinical 
environments. Motility over surfaces is a survival strategy that contributes to bacterial ability to colonize 
different surfaces and to develop biofilms.  
This work aimed to compare the virulence behaviour of a series of five P. aeruginosa clinical isolates, 
namely the motility phenotype and to assess whether this bacterial trait could be related to biofilm formation 
ability and biofilm resistance to benzalkonium chloride (BC) and ciprofloxacin (CIP).  
Biofilm tolerance was assessed by the determination of the bactericidal effect of 1x, 4x and 16x the MIC of 
each antimicrobial in biofilm development and survival.  
Results showed that one of the most motile isolated strains was the stronger biofilm former. Biofilms formed 
by the less motile strain, that exhibited reduced biofilm mass, activity and number of cells, showed however 
increased resistance to BC and CIP. Although high flagellated bacteria may have advantages amongst the 
other strains in terms of colonization, data suggest that the presence of appendages has no relation with 
biofilm resistance to BC and CIP. Biofilm tolerance was observed for all the clinical isolates, as higher 
values of biofilm mass and activity were observed after biofilm exposure to 16x MIC of BC and CIP in 
comparison with the reference strain. 
This study suggests that the presence of isolates can confer biofilms greater phenotypic variability that may 
contribute to the easiness of biofilm adaptation to external antimicrobial pressures and subsequent 
recalcitrance to antimicrobial treatments. This work also reinforces the need of determining the biofilm-
forming ability and the sensitiveness to in-use antimicrobials of each clinical bacterial isolate not only in 
planktonic cultures, but also in the biofilm mode of growth, following standardized operational procedures. 
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3.1.1 INTRODUCTION 
Pseudomonas aeruginosa, an opportunistic high flagellated pathogenic bacterium, has been widely 
investigated for its association with a ample variety of nosocomial infections and high incidence in 
clinical surfaces8. The pathogenesis of P. aeruginosa is due to the production of a vast diversity of 
virulence factors including secreted factors (such as lipopolysaccharides and flagella)22, as well as 
the ability to form biofilms20. P. aeruginosa is capable of three types of motility: twitching, 
swimming and swarming. Twitching is mediated by type IV pili on solid substrates, whilst 
swimming and swarming are mediated by the flagellum in aqueous environments7. Cellular 
appendages, including motility structures, like flagella, and adhesive structures like type IV pili 
and other nonpilus adhesins, are important for attachment to abiotic surfaces and for the 
establishment of infection in the epithelial cells. Various studies13,16,21 have addressed bacterial 
motility both as means of initiating contact with surfaces and in biofilm formation and maturation. 
Previous studies related with bacteria attachment and early-stage of biofilm formation have 
demonstrated that flagellar-based swimming and type IV pili-dependent twitching are important 
for bacterial adhesion. The most noted pathogenic ability of P. aeruginosa is the colonization of 
patients and contamination of medical devices through the development of strong biofilms, which 
are often hard to eradicate with conventional strategies. Biofilms can be defined as structured 
communities of microorganisms encased in a self-produced polymeric matrix attached to inert or 
biotic surfaces5. The biofilm-growing cells acquire physiological characteristics that differentiate 
them from planktonic cells, being in part responsible for the increased resistance towards 
antimicrobial treatment6. When P. aeruginosa is found in clinical settings, efforts should be made 
to substantiate its clinical relevance, namely determining its pathogenicity and the most effective 
antimicrobials for its complete eradication. In fact, it has been noticed notable differences in 
virulence traits and degrees of innate resistance between the majorities of P. aeruginosa clinical 
isolates. Those efforts must also encompass strategies to avoid the establishment and recalcitrance 
of further bacterial adhesion and biofilm development2.  
The aim of this work is to characterize and compare clinical isolates of P. aeruginosa regarding 
their motility, biofilm-forming ability and to determine whether biofilms might have augmented 
tolerance towards benzalkonium chloride (BC) and ciprofloxacin (CIP). 
3.1.2 MATERIAL AND METHODS 
Strains and culture conditions  
P. aeruginosa ATCC 10145 and P. aeruginosa clinical isolates (catalogued as I93488, I92986, 
I97824, C80117 and U147016) were used in this work. Bacteria were preserved and cultured as 
described in sub-chapter 2.1. 
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Antibacterial Agents 
Benzalkonium Chloride (BC) was used throughout this work. 
Bacterial motility 
To evaluate the motility ability of each bacterial strain, swimming, swarming and twitching assays 
were performed as described in sub-chapter 2.2.4. 
 
Biofilms  
The methodology used to grow the bacterial biofilms was based on the microtiter plate test 
developed by Stepanovic et al.18, as described in sub-chapter 2.4.1.3 
Biofilm Treatment 
The wells-attached biofilms were subsequently treated with 200 μL of 1280 mg/L (8x MIC) of BC 
or 1 mg/L (8x MIC) of CIP for 30 min. Non-treated wells were filled with 200 μL of UP sterilized 
water for the same period of time. After that, the content of each well was removed and biofilms 
were washed with 200 μL of UP sterilized water and reserved for subsequent analyses (see below). 
BC and CIP bactericidal activity in biofilms 
The determination of bactericidal effect of BC and CIP in biofilm development was based on the 
procedure described by Riera et al.17. In order to determine the concentrations to be evaluated, the 
MIC and the minimum bactericidal concentration (MBC) of the reference strain were determined 
as described in sub-chapter 2.2.1. 
Biofilms were formed for 24 h as previously described and incubated for additional 24 h in TSB at 
0x, 1x, 4x and 16x the MIC of BC and CIP. Afterwards, biofilms were washed twice with UP 
sterilized water and characterized as described below. 
Biofilm mass  
The biomass of P. aeruginosa biofilms was quantified by the crystal violet (CV) staining method 
adapted from Stepanovic et al.18 according to the procedure described in sub-chapter 2.4.4.2. 
Biofilm activity 
Biofilm activity was determined with the 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide sodium salt (XTT) colorimetric method by Stevens and Olsen19 as 
described in sub-chapter 2.4.4.3. 
Biofilm cell enumeration 
The enumeration of P. aeruginosa biofilm cells was performed by colony counts following the 
procedure described in sub-chapter 2.4.4.4. 
Motility, biofilm forming ability and tolerance development of P. aeruginosa clinical isolates Chapter 3.1 
 
 63 
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism, version 4.0 software for Macintosh. 
Normality of data distribution was tested by the Kolmogorov-Smirnov method. Statistical 
significance values of the groups’ means of biofilm biomass, biofilm activity and cell number 
were evaluated using a one-way analysis of variance. The statistical analyses performed were 
considered significant when p <0.05. 
 
3.1.3 RESULTS 
Bacterial motility 
In order to evaluate the motility ability of the isolated strains, swimming, swarming and twitching 
assays were performed (Fig.3.1-1). Macroscopic observations of the colony pattern in the LB 
media, with specific density, revealed that the clinical isolates exhibit different motility structures 
and/or colony appearance. 
Fig.3.1-1 Macroscopic observations of the motility assays of P. aeruginosa ATCC 10145 
and clinical isolates I93488, I92986, I97824, C80117 and U147016. Bar represents 0.5 cm. 
 
P. aeruginosa Swimming Swarming Twitching 
ATCC 10145 
   
I93488 
   
I92986 
   
I97824 
   
C80117 
   
U147016 
   
Chapter 3.1 Motility, biofilm forming ability and tolerance development of P. aeruginosa clinical isolates 
 
  
 
64 
Concerning swimming ability (Fig.3.1-1), all the tested strains exhibited similar swimming 
patterns through a relatively low-viscosity environment, as the diameter of the migration zones 
produced by the isolates were not significantly different (p>0.05). In terms of swarming motility, 
the reference strain and the clinical isolates I93488 and I97824 showed swarming rings with the 
largest diameter among the strains evaluated while C80117 and U147016 formed the smallest 
colonies (Fig.3.1-1). Regarding twitching motility, the I93488 strain revealed to be the strain able 
to develop colonies with the largest diameter and more irregular borders (Fig.3.1-1, Twitching). 
Biofilm phenotype 
Biofilm phenotypic characterization shows that, in general, the 48-h-old biofilms have higher 
values of biomass, activity and number of cells than those observed for 24-h-old biofilms (Fig.3.1-
2 A). The exceptions were the reference strain that exhibited similar values of biofilm activity at 
both periods of biofilm development, and the clinical isolate I93488 that showed less number of 
cells entrapped in the older biofilms. 
 
 
C 
 
Fig.3.1-2 Biofilm mass (OD570) (A), metabolic activity (OD490) (B) and number of cultivable cells (C) of 24-h-old 
(withe) and 48-h-old (grey) biofilms of P. aeruginosa ATCC 10145 and clinical isolated strains I93488, I92986, I97824, 
C80117 and U147016. Bars represent the average of three independent repeats ± SD. 
 
 
After 24 h of biofilm growth, P. aeruginosa isolated strain I93488 exhibited the highest biofilm-
formation ability (p<0.05) (Fig.3.1-2 a) compared with the other clinical isolates and the reference 
strain (Fig.3.1-2). Conversely, P. aeruginosa U147016 is the strain that formed biofilms with less 
A 
 
B 
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biomass (p<0.05) and lower respiratory activity (p<0.05). However, after 48 h of biofilm growth, 
this isolated strain displayed biofilms with superior activity and number of cells when compared 
with the reference strain. All other strains exhibited similar biofilm respiratory activity after 24 h 
of growth (p>0.05). After 48 h of biofilm development, the clinical isolate C80117 was the strain 
that developed biofilms with higher respiratory activity (Fig.3.1-2b). The number of biofilm-
entrapped cells was similar for all the strains and for both periods of biofilm development (Fig.3.1-
2c). 
These results indicate that all the strains are good biofilm producers, although the clinical isolates 
stand out relatively to the reference strain when biofilm respiratory activity is analysed. 
 
Bactericidal effect of BC and CIP in biofilm development 
In order to assess the antimicrobial effects of BC and CIP during biofilm development, 24-h-old 
biofilms were allowed to growth for additional 24 h in the presence of 0x, 1x, 4x and 16x the MIC 
of each antimicrobial agent. The MIC of BC and CIP for the P. aeruginosa reference strain was 
respectively 160 and 0.125 mg/L. The results regarding the evaluation of the bactericidal activity 
of BC and CIP in biofilm development are shown in Fig.3.1-3 and Fig.3.1-4.  
The presence of 160 mg/L of BC (1x the MIC value) during biofilm development reduced the 
biofilm mass for all the strains, with the exception of the reference strain and the clinical isolate 
C80117 (Fig.3.1-3 A). However, the application of the highest BC concentrations did not reduce 
biofilm biomass in comparison with the control biofilms. In general, biofilm treatment with 4x 
MIC of BC (640 mg/L) increased the biofilm mass, as indicated by the increase in the OD570 
values when compared to the untreated controls (0x MIC). Similar behaviour was observed for 
biofilms developed in the presence of the highest BC dose tested, 2560 mg/L (16x MIC of BC). 
Data shown in Fig.3.1-3 A suggests that under this concentration treatment, all the strains 
produced biofilms with higher biomass than the corresponding untreated controls, developed only 
in TSB for 48 h (p<0.05). Moreover, at 2560 mg/L of BC, with the exception of C80117 and 
U147016 strains, biofilms developed by the clinical isolates presented more biomass than the 
biofilms developed by the reference strain. Regarding biofilm respiratory activity data (Fig.3.1-3 
B), in general, the 48-h-old biofilms showed a reduced activity, this reduction being proportional 
to the BC concentration used to growth the P. aeruginosa biofilms. 
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Fig.3.1-3 Biofilm mass (OD570 nm) (A), metabolic activity (OD490 nm) (B) and number of cultivable cells (C) of 24h-
biofilms developed for additional 24h in the presence of 0x, 1x, 4x and 16x the MIC of P. aeruginosa ATCC 10145 to 
BC (160 mg/L). Biofilms were formed by ATCC 10145(☐) and isolated strains I93488 (▥), I92986(▦), I97824 (▤), 
C80117 (▨), U147016(). Bars represent the average of three independent repeats ± SD.  
The presence of 640 mg/L of BC during biofilm growth caused a high reduction in the respiratory 
activity of the biofilms developed by the P. aeruginosa isolates when compared with control 
biofilms (p<0.05). The increase in the BC concentration, from 640 mg/L (4x MIC) to 2560 mg/L 
(16 x MIC) of BC did not promote higher activity reduction than that observed at 4 x MIC 
(p>0.05). However, in terms of culturable cells, the results obtained reveal that 2560 mg/L BC 
(16x MIC) (Fig.3.1-3 C) promoted a reduction of approximately 8 log10/cm2 in the number of 
biofilm-entrapped cells for all the strains. 
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Concerning the development of biofilms in the presence of CIP (Fig.3.1-4), in general, it was 
observed a dose-dependent biomass reduction for all the strains (Fig.3.1-4 A), with the exception 
of biofilms developed by the U147016 strain. In fact, this clinical isolate developed biofilms with 
similar values of biomass despite the CIP dose assayed (from 0 to 2 mg/L) (p>0.05) (Fig.3.1-4 A).  
A 
 
B 
 
C 
 
Fig.3.1-4 Biofilm mass (OD570 nm) (A), metabolic activity (OD490 nm) (B) and number of cultivable cells (C) of 24h-
biofilms developed for additional 24h in the presence of 0x, 1x, 4x and 16x the MIC of P. aeruginosa ATCC 10145 to 
CIP (0.13 mg/L). Biofilms were formed by ATCC 10145(☐) and isolated strains I93488 (▥), I92986(▦), I97824 (▤), 
C80117 (▨), U147016(). Bars represent the average of three independent repeats ± SD. 
The presence of the higher CIP concentration tested (2.0 mg/L) during biofilm development did 
not promote any considerable decrease in biofilm cells respiratory activity when compared with 
the biofilms developed in the absence of CIP, for all the strains, except for the reference strain 
(p<0.01). At the higher CIP concentration tested (2.0 mg/L) all the biofilms developed by clinical 
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isolates showed higher values of activity when compared with those developed by the reference 
strain (p<0.001). 
Concerning the effect of CIP on the biofilm-entrapped cells (Fig.3.1-4 C), it was observed a 
reduction of about 3 log10/cm2 in the number of I97824 culturable cells after biofilms exposure to 
0.5 mg/L of CIP (4x MIC) in comparison with the untreated controls. The highest CIP 
concentration, 2.0 mg/L (16x MIC), disturbed P. aeruginosa ATCC 10145 biofilms, promoting a 
reduction in the number of cells of about 2 log10/cm2 (Fig.3.1-4 C). The use of 2.0 mg/mL of CIP 
on biofilm development by the clinical isolates did not cause any significant reduction in 
comparison with the biofilms developed in the absence of CIP (Fig.3.1-4 C). 
 
3.1.4 DISCUSSION 
Biofilms are sessile communities of microorganisms adhered to a surface and enclosed in an 
extracellular matrix. In most environments, bacteria are thought to reside predominantly in 
biofilms rather than in a planktonic or free swimming state4. P. aeruginosa is capable of three 
types of motility. Specifically, twitching motility is mediated by type IV pili on solid substrates, 
whilst swimming and swarming motility are mediated by the flagellum in aqueous environments7. 
During biofilm formation, flagella or flagella-mediated motility are important for the 
establishment of the bacterial monolayer and to bring the cell within close proximity to the 
surface, overcoming repulsive forces between the bacterium and the surface7. Furthermore, type 
IV pili appear to play a role in the stabilization of the interactions between the abiotic surface 
and/or in the cell-to-cell interactions required to form a microcolony, therefore contributing for 
biofilm formation16. 
In this study, it was aimed to inspect the virulence traits of five P. aeruginosa clinical isolates 
regarding their motility phenotype and to assess whether this bacterial trait could be directly 
related to biofilm formation ability and biofilm resistance to a frequently used antimicrobial 
product (BC) and to an antibiotic commonly prescribed to treat P. aeruginosa infections (CIP).  
Results presented in Fig.3.1-1 (Swarming) reveal that the strain I93488 showed the highest 
swarming phenotype. Swarming is a type of social motility that allows rapid colonization of 
surfaces by highly differentiated swarm cells12,14. It has been also pointed out that swarmer cells 
are more resistant to several types of antimicrobials11,14. As swarming is a type of collective 
locomotion, the concept of a unique resistant phenotype when cells are organized as a society is 
emerging and has been named as a “social phenomena”14. Moreover, P. aeruginosa I93488 was 
also the strain that formed colonies with highest diameter in the twitching assays (Fig.3.1-1). As 
referred previously biofilm formation has been linked to twitching motility14 and in accordance, 
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this strain exhibited the thickest biofilms after 24 h of growth and, together with the clinical isolate 
I92986, also at 48 h of biofilm development (Fig.3.1-2).  
Biofilms formed by P. aeruginosa I93488 strain were also the ones that suffered less mass 
reduction after treatment with both BC (Fig.3.1-3) and CIP (Fig.3.1-4). To expand previous 
knowledge, the BC and CIP bactericidal effects on 24-h-old biofilms formed by P. aeruginosa 
clinical isolates were evaluated and compared. For that, the 24-h-old biofilms were allowed to 
growth for more 24 h in the presence of 1x, 4x and 16x of MIC of each antimicrobial agent 
determined for the P. aeruginosa ATCC 10145. Results showed that all the strains were able to 
develop biofilms when antimicrobial pressure exists. In fact, the increase in BC and CIP 
concentrations to values of 4x the MIC (Fig.3.1-3 and Fig.3.1-4) was not able to completely 
eradicate P. aeruginosa biofilms. The biofilms formed by the isolated strains revealed high 
tolerance to CIP, even at 16x the MIC (Fig.3.1-4). Despite the fact that BC showed ability to 
significantly reduce the number of cultivable biofilm-entrapped cells, the complete eradication of 
biofilms was not achieved as total reduction of biofilm mass or activity was not attained (Fig.3.1-
3). These data are in accordance with those reported by Delissalde8, that pointed out that P. 
aeruginosa clinical strains were more capable to form biofilms than reference strains, displaying 
resistant phenotypes. 
The overall results also show that the isolate U147016, a strain that was characterized as non-
motile, developed biofilms with less mass, activity and number of cells after 24h of biofilm 
formation (Fig.3.1-2). However, at 48 h of biofilm growth, this strain formed biofilms with the 
higher values of mass, activity and number of cells. In fact, no significant adverse effect was 
observed on biomass or activity when biofilms formed by U147016 were after developed in the 
presence of high-doses of antimicrobial products (Fig.3.1-3 and Fig.3.1-4). 
Bacterial appendages are not only related with locomotion and biofilm formation, but also play a 
role in pathogenesis3,16. Clinical isolates, frequently exposed to stress conditions in a hospital 
environment, can suffer a selection process that favours more motile and/or more pathogenic 
strains9,10. As the number of isolated strains was not representative, no robust conclusion can be 
anticipated. However, with the strains tested, it can be stated that flagella and pili IV are in the 
origin of biofilm development, and in some cases, may be related to BC and CIP resistance. 
However, it was not found any relationship between the denser biofilms formed by the motile 
strains and higher biofilm resistance of P. aeruginosa clinical isolates biofilms.  
Results also revealed that, high-doses (16x MIC) of BC and CIP applied in biofilms during 24 h, 
instead of eradicating the cells may contribute to biofilm-entrapped cells persistence, which may 
be on the basis of biofilm subsistence in natural environments. Even if the reduction of cultivable 
cells within the biofilm was almost total, especially after treatment with the higher concentration 
of BC tested, the reduction of biofilm mass and activity was not accomplished. When the level of 
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antimicrobial drops the small fraction of biofilm-entrapped cells that remain alive and protected 
within the biofilm matrix1 are able to multiply and repopulate the biofilm allowing the bacteria to 
persist attached to the surface15. This fact may be on the basis of biofilm persistence in hospital 
environments where bacteria are permanently exposed to antimicrobial products. In general, the 
BC action was superior to CIP against 24-h-old biofilms, but none of the products revealed to be 
completely effective. A better understanding of the mechanism of action of BC and CIP, and the 
resulting response elicited by P. aeruginosa clinical isolates to these antimicrobial agents will 
facilitate its effective utilization for P. aeruginosa biofilm control in critical environments. 
In real scenarios P. aeruginosa surface isolates can confer greater phenotypic variability to 
biofilms that may contribute to the easiness of adaptation to external antimicrobial pressures and 
subsequent biofilm persistence after antimicrobial treatments and cleaning practices. This study 
underlines that the bacterial sensitiveness to antimicrobials should be tested not only in planktonic 
cultures, but also with standardized operational procedures to evaluate biofilm formation ability as 
well as biofilm resistance to in-use antimicrobial products. 
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CHAPTER 3.2 
 
 
ANTIMICROBIAL PRESSURE OF CIPROFLOXACIN AND GENTAMICIN ON BIOFILM 
DEVELOPMENT BY AN ENDOSCOPE ISOLATED PSEUDOMONAS AERUGINOSA – ROLE 
OF PERSISTER CELLS ON BIOFILM RECOVERY 
This work aims at characterizing and comparing endoscope biofilm-isolated (PAI) and wild-type P. 
aeruginosa (PA) initial adhesion, biofilm formation ability and sensitivity to antibiotics. Additionally, the 
recovery ability of the biofilm-growing bacteria subjected to intermittent antibiotic pressure with 
ciprofloxacin (CIP) and gentamicin (GM), as well as the development of resistance towards antibiotics and a 
disinfectant, benzalkonium chloride (BC), were also determined. 
Data showed that both strains have high ability to adhere to surfaces and are good biofilm producers. 
However, PAI was able to adhere in higher extent and to form thicker biofilms. The capacity of both strains 
to develop biofilms was greatly impaired in the presence of CIP and GM. However, sanitization was not 
complete allowing always the recovery of the P. aeruginosa biofilms following the intermittent cycles of 
antibiotic pressure. This cycle of biofilm decrease/biofilm recovery may be due to the selection of persister 
cells able to survive the antibiotic selective pressure, ensuring biofilm survival. The environmental pressure 
exerted by CIP and GM did not developed P. aeruginosa resistance to the same antibiotics or cross-
resistance towards BC. However, data highlighted that none of the antimicrobials led to complete 
eradication of the biofilms, allowing the recovery of the remaining adhered population. This feature may 
lead to biofilm recalcitrance, reinforcing bacterial attachment and the re-colonization of other accessible 
sites by persister cells. 
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3.2.1 INTRODUCTION 
Pseudomonas aeruginosa is an opportunistic pathogenic bacterium7 widely investigated for its 
high incidence and extraordinary ability to form strong biofilms in clinical equipment, medical 
devices and wounds5,19. This microorganism is commonly associated with nosocomial infections 
and is a leading cause of severe and life-threatening infections, specially in immunosuppressed 
hosts29. P. aeruginosa is one of the most common microorganisms transferred by bronchoscopes, 
being the most frequent in gastrointestinal endoscopy4. Flexible endoscopes undergo repeated 
rounds of patient-use and reprocessing. Studies related to endoscope contamination have reported 
the presence of biofilms on the inner surface of endoscope channels10,21, highlighting the 
importance of effective measures for cleaning and disinfection in endoscope reprocessing. Biofilm 
removal is a crucial step to prevent lapses in reprocessing being thus of clinical relevance in 
endoscopy4,27. Biofilms represent a reservoir of pathogenic bacteria that can detach, resume their 
planktonic state, and contaminate new surfaces and patients. Moreover, microbial biofilms are 
notorious for their high level of resistance towards antibiotic and biocide treatments13. Bacteria 
within biofilms can easily live in the presence of high antibiotic concentrations similar to the ones 
that are prescribed during the course of therapies9,36. Biofilm resistance mechanisms involve not 
only the reaction-diffusion limitation of antimicrobial access to the biofilm-entrapped bacteria14,41, 
but also the expression of spatially heterogeneous, less susceptible phenotypes, caused either by 
growth as a biofilm per se12 or through the expression of high cell density6, or starvation 
phenotypes11. Antibiotics and biocides are frequently used in hospitals with the purpose to control 
the growth of, or to kill bacteria in, respectively, infection control and sanitation. The use of 
certain active substances in biocides in various settings may contribute to the increased occurrence 
of antibiotic resistant bacteria. Cross-resistance between biocides and antibiotics and between 
different antibiotics has been reported previously25, and there are several studies suggesting that if 
two antimicrobial compounds have similar mechanisms of action, they may also share resistance 
mechanisms35. It has also been demonstrated that highly antibiotic-resistant clinical isolates of 
Gram-negative bacteria are generally more resistant to disinfectants22. Although there is much 
concern regarding the risks of antibiotic resistance induced by the use of and resistance to 
biocides, there is a lack of studies evaluating the performance of disinfectants after bacterial 
exposure to antibiotics. Studies related with the use of sessile bacteria to assess the efficacy of 
antibiotics and biocides are even lesser, even though biofilm formation is an important aspect of 
many bacterial diseases. These biofilm tests should also include bacteria isolated from real 
scenarios as they can present genetic diversity and thus possess distinct virulence factors. The 
pathogenesis of P. aeruginosa is attributed to the production of several cell-associated and 
extracellular virulence factors that arise under certain environmental conditions42. 
Chapter 3.2 Antimicrobial pressure of CIP and GM on biofilm development by an endoscope isolated P. aeruginosa 
 
  
 
76 
In the present work, the phenotype (early-stage adhesion, biofilm formation and sensitivity to 
antimicrobials) of P. aeruginosa isolated from a biofilm formed on an endoscope was determined 
and compared with the wild-type. Furthermore, this study was also undertaken to determine 
whether exposure of P. aeruginosa biofilms to intermittent cycles of antibiotic chemotherapy 
[ciprofloxacin (CIP) and gentamicin (GM)] could lead to regrowth and potential resistance and 
cross-resistance towards BC, CIP and GM.  
3.2.2 METHODS 
Test organisms and culture conditions  
Pseudomonas aeruginosa (ATCC 10145) (PA) and Pseudomonas aeruginosa isolated (PAI) from 
a biofilm formed in a medical device (gastrointestinal endoscope) were used throughout this work. 
Bacterial suspensions were prepared as described in sub-chapter 2.1.3. 
Antibacterial and antibiotic agents 
Ciprofloxacin (CIP), Gentamicin (GM), and Benzalkonium chloride (BC), were used. The 
antibiotics concentrations used in the present work were determined using, as reference the 3x 
MBC1 of each product for the reference strain. So, for biofilm disturbance cycles and biofilm 
treatment, a concentration of 3 mg/L of CIP and 10 mg/L of GM were used. Concerning BC, the 
MBC concentration of 320 mg/L was used. 
Early bacterial adhesion 
In order to determine the adhesion ability of both strains, a parallel plate flow chamber (PPFC) and 
image analysis system were used to study the early-stage bacterial adhesion and detachment, as 
described by Sjollema et al.38 according with the procedure described in sub-chapter 2.3.3. 
The initial increase in the number of adhering microorganisms with time was expressed as the so-
called initial deposition rate [j0, cells/(cm2 s)], i.e., the number of adhering microorganisms per 
unit area and time. The number of adhering microorganisms after 30 min of bacterial suspension 
flow [n30, cells/(cm s)] as well as the number of microorganisms after PBS passage [n60, cells/(cm 
s)] were also determined. The rate of detachment (%) denotes the percentage of P. aeruginosa 
cells that were detached upon the passage of PBS trough the flow chamber. 
Biofilm formation 
The biofilm formation ability of PA and PAI on polystyrene (PS) was inspected along time (24, 
48, 72, and 96 h) using the microtiter plate test developed by Stepanovic et al.39 as described in 
sub-chapter 2.4.1. After 24 h of biofilm growth, the supernatant containing planktonic cells and 
media was removed. The wells were re-filed with fresh TSB and this process of supernatant 
removal and media filling was repeated for every 24 h until 96 h of biofilm formation.  
After 24, 48, 72, and 96 h of growth, biofilms were characterized in terms of biomass, respiratory 
activity and number of viable biofilm-entrapped cells. 
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Biofilm disturbance and recovery 
To assess whether the presence of antibiotics could interfere with the establishment of biofilms by 
both strains on PS surfaces, biofilms were allowed to form for 24 h in the presence of both 
antibiotics. To ascertain the post-antibiotic effects (PAE) of CIP and GM on P. aeruginosa, those 
challenged biofilms were later subjected to intermittent cycles of antibiotic chemotherapy with 
CIP and GM. Biofilms were formed in microtiter plates with cell suspensions of both strains at a 
final concentration of 1.0 x 107 cfu/mL prepared in TSB containing CIP or GM in a final 
concentration of respectively, 3.0 mg/L or 10 mg/L. Each cycle of antibiotic treatment was 
followed by a recovery period of 24 h, where biofilms were developed in 200 μL of fresh TSB. 
After 24, 48, 72, and 96 h the content of each well was removed, biofilms were washed and 
phenotypically characterized. 
Biofilm susceptibility 
The 96-h-old biofilms untreated and submitted to the intermittent antibiotic chemotherapy with 
CIP and GM were inspected regarding their susceptibility towards the same antibiotics as well as 
the potential occurrence of cross resistance towards the disinfectant BC. In order to determine the 
biofilm response after antibiotic therapy, biofilms were treated with 200 μL per well of 360 mg/L 
of BC, 3 mg/L of CIP or 10 mg/L of GM for 30 min. Non-treated wells were filled with 200 μL of 
UP sterilized water. After that, the content of each well was removed and biofilms were washed 
with 200 μL with ultrapure sterilized water (UP) being reserved for posterior analysis. 
Biofilm analyses 
Biofilm mass, activity and number of cells 
Biomass of P. aeruginosa biofilms was quantified by crystal violet (CV) staining method adapted 
from Stepanovic et al.39 described in sub-chapter 2.4.4.2. Biofilm activity was determined with 
2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide (XTT) colorimetric 
method colorimetric method as described by Stevens and Olsen40, and referred in sub-chapter 
2.4.4.3.The number of viable biofilm-entrapped bacteria from biofilm suspensions was determined 
according with the procedure described in sub-chapter 2.4.4.4. 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism, version 4.0 software for Macintosh. 
Normality of data distribution was tested by the Kolmogorov-Smirnov method. Statistical 
significance values of the groups’ means of biofilm mass, biofilm activity and cell number were 
evaluated using a one-way analysis of variance. Subsequent comparisons were performed using 
Tukey’s post-hoc test. Two-way analysis of variance with Bonferroni post-hoc test were used to 
compare means of biofilms obtained after 96 h, and after CIP and GM regrowth cycles after 
treatment.  The statistical analyses performed were considered significant when p <0.05. 
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3.2.3 RESULTS 
Attachment and detachment monitoring 
The results obtained with early bacterial adhesion assay (Table 3.2-1) revealed that both strains 
had high ability to adhere to surfaces, but the rate of cell deposition (j0) of the isolated strain was 
higher than that of PA (p<0.05). After 30 min of adhesion, the number of adhered cells (n30) is 
about twice for the isolated strain (p<0.05). Also, the number of PAI cells that remained attached 
in the PS surface (n60) was the double of PA cells (p<0.05), being the percentage of detachment of 
PA cells after PBS passage of about 20%. 
Table 3.2-1 Initial deposition rate (j0), number of adhered cells, (n30 min), number of adhered cells after PBS passage 
(n60 min), and percentage of detachment determined through the parallel plate flow chamber. Values are means ± SD 
for three measurements. 
 j0 
(103 cells/(cm2 s)) 
n30 min 
(107 cells/cm2) 
n60 min 
(107 cells/cm2) 
Detachment 
(%) 
P. aeruginosa ATCC 10145 3.9 ± 1.2 4.56 ± 0.8 3.62 ± 0.5 20.6 
P. aeruginosa isolated strain 6.3 ± 2.0 7.49 ± 1.4 7.34 ± 1.2 2.0 
 
Biofilm formation 
In order to examine the biofilm formation ability of both PAI and PA strains, the biofilm 
phenotype was characterized in terms of mass, activity and number of cells after 24, 48, 72 and 96 
h of growth (Fig.3.2-1). 
 
A 
 
B 
 C 
 
Fig.3.2-1 Biofilm mass (OD570) (A), metabolic activity (OD490) (B) and number of biofilm-entrapped cells (C) of P. 
aeruginosa ATCC (grey) and P. aeruginosa isolated strain (black) biofilms. Biofilms where grown in TSB and 
characterized at 24, 48, 72 and 96 h. Bars represent the average of 3 independent repeats ± SD. 
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In general, data showed that mass and activity of biofilms increased along time, whereas the 
number of biofilm-entrapped cells was approximately in the same magnitude, for all the time 
periods of biofilm formation. Comparing both strains, Fig.3.2-1 shows that, in general, PAI gave 
rise to biofilms with more mass than PA (p<0.05) and activity (p<0.05). The number of biofilm 
cells (Fig.3.2-1C), was identical to those quantified for PA biofilms, except for 72-h-old and 96-h-
old biofilms in which there was an increase in the number of cells (p<0.001). These results 
indicate that both strains are good biofilm producers although the isolate stands out relatively to 
the collection. The presence of CIP and GM in the first 24 h of biofilm development clearly 
hampered the establishment of biofilms by both strains on PS surfaces (Fig.3.2-2). 
 I II 
A 
  B 
  
C 
  
Fig.3.2-2 Biofilm mass (OD570) (A), metabolic activity (OD490) (B), and number of cultivable cells (C), of P. aeruginosa 
ATCC (grey) and P. aeruginosa isolated strain (black) biofilms. Biofilms where grown in 24 h cycles in TSB (I) + 3 
mg/mL CIP or (II) in TSB + 10 mg/mL GM and TSB during 96 h. Bars represent the average of 3 independent repeats ± 
SD. 
In fact, the phenotype of PA and PAI biofilms grown for 24 h under antibiotic pressure was 
characterized by a large decrease in biofilm mass and activity (about 95%) and a reduction of 
about 4 log in the number of viable biofilm-entrapped cells. However, it must be emphasized that a 
considerable number of cells remained viable on the surfaces. These data revealed that CIP and 
GM have a significant in vitro anti-biofilm formation activity, this effect being similar for both 
strains. 
After a recovery period of 24 h, where growth occurred in absence of antibiotics, those remaining 
less dense biofilms recovered its levels of biomass, activity and number of cells (Fig.3.2-2). 
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Biofilm recovery post CIP pressure (Fig.3.2-2I) gave rise to PAI biofilms with higher values of 
biomass (p<0.001), activity and viable cells (p<0.01), when compared with PA biofilms. This 
trend was similar to that observed in the 48-h-old biofilms formed without any stress factor 
(Fig.3.2-1). Regarding the post-GM effect (Fig.3.2-2II), the superiority of the biofilms formed by 
the isolated strain is no longer evident as PAI biofilms only showed higher biomass (p<0.001). 
The second cycle of biofilm growth under antibiotics pressure clearly reduced the mass, activity 
and number of biofilm-encased cells, for both strains (Fig.3.2-2). However, these reductions were 
lower than those obtained after the first cycle of antibiotic treatment, mainly when GM was used. 
These results showed that both antibiotics have ability to disturb established P. aeruginosa 
biofilms causing its removal and inactivation. Nevertheless, as Fig.3.2-2 shows, this sanitation was 
not total, allowing biofilm regrowth during the second recovery period. In fact, the resulting 96-h-
old biofilms recuperated again its levels of biomass and activity, although they are far from those 
observed in biofilms developed by both strains in the absence of antibiotic stress (Fig.3.2-1). The 
numbers of viable biofilm-cells were also restored reaching however values in the same order of 
magnitude of those determined in the 96-h-old biofilms formed in TSB. Comparing the behaviour 
of both strains, in general, PAI biofilms showed higher biomass, activity and number of cells than 
the biofilms formed by the reference strain. 
The post-antibiotic effects observed after the second cycle of antimicrobial treatment is similar to 
that observed after the first biofilm growth under antibiotic pressure, except for biofilm activity 
(Fig.3.2-2). In fact, the activity of the 96-h-old biofilms was higher than those observed after the 
first 24-h recovery period, specially for biofilms grown under GM pressure (p<0.001) and for 
those developed by PAI (p<0.001) (Fig.3.2-2B). 
The overall results highlighted that both antibiotics have good anti-biofilm characteristics and 
ability to remove and inactivate established P. aeruginosa biofilms. Nevertheless, sanitization was 
not complete allowing the resumption of the biofilms immediately following antibiotic pressure. 
The susceptibility of the 96-h-old biofilms, subjected to the intermittent cycles of antibiotic 
pressure, towards antibiotics (GM and CIP) and biocide (BC) treatment can be observed in 
Fig.3.2-3. 
In the range of conditions tested, the 96-h-old biofilms formed by both strains in TSB were 
practically tolerant to the action of antibiotics and susceptible to the toxic effect of BC. In fact, 
only treatment with BC of PA and PAI biofilms promoted a significant reduction of biomass 
(Fig.3.2-3A)(p<0.001), respiratory activity (Fig.3.2-3B)(p<0.001), and number of viable cells 
(Fig.3.2-3C)(p<0.001). 
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Fig.3.2-3 Biofilm mass (OD570) (A), metabolic activity (OD490) (B) and number of cultivable cells (C) of 96 hours 
biofilms of P. aeruginosa ATCC (I) and P. aeruginosa isolated strain biofilms (II). Biofilms were developed in TSB, 
CIP and GM therapy. Normal Biofilms (control, white) and treated with BC (light grey), CIP (dark grey), and GM 
(black). Bars represent the average of 3 independent repeats ± SD. 
The 96-h-old biofilms formed by both the ATCC and the isolated strain under intermittent cycles 
of CIP or GM pressure were also clearly disturbed by the action of BC. It appears that antibiotic 
pressure during biofilm growth gave rise to biofilms more susceptible to the antimicrobial action 
of benzalkonium chloride. 
The response of PA biofilms towards CIP and GM treatment depended on the antibiotic used. The 
PA biofilms challenged by CIP pressure (Fig.3.2-3I) are practically indifferent to the posterior 
aggression with the same antibiotic, as the values of biofilm mass (Fig.3.2-3I-A) and activity 
(Fig.3.2-3I-B) were higher than those observed in biofilms without treatment (p<0.01), although 
there was a reduction in the number of viable biofilm-cells (p<0.001) (Fig.3.2-3I-C). The response 
of these biofilms to the action of GM was somewhat different, as GM caused the reduction of 
biofilm metabolic activity and number of biofilm-entrapped cells. 
The 96-h-old biofilms formed under GM intermittent pressure appeared to be more tolerant 
towards both antibiotics, as the aggression of CIP and GM for 30 min only decreased the number 
of viable biofilm-cells (p<0.001) (Fig.3.2-3I-C). 
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Regarding PAI biofilms (Fig.3.2-3II), those developed under CIP pressure were more sensitive to 
the action of GM than CIP, since only significant reductions in biofilm mass (p<0.001) (Fig.3.2-
3II -A), respiratory activity (p<0.001) (Fig.3.2-3II-B), and number of viable cells (p<0.001) 
(Fig.3.2-3II-C), were observed after GM treatment. The action of CIP and GM against the 96-h-
old PAI biofilms, previously grown under GM pressure, were quite similar as both antibiotics 
increased the biomass accumulated on the PS surfaces (Fig.3.2-3II-A)(p<0.05) and slight 
decreased the biofilm activity (Fig.3.2-3II-B) (p<0.05) and the number of the biofilm-cells 
(Fig.3.2-3II-C)(p<0.001). 
Based on Fig.3.2-3, it can be stated that none of the conditions led to complete sanitation of the 
biofilms, being, in general, the action of the antimicrobials more effective in bacteria inactivation 
than in biofilm removal. Data also highlighted that cross-resistance between antibiotics and the 
biocide did not occur. 
3.2.4 DISCUSSION 
Adhesion and biofilm formation are two important aspects of many bacterial diseases, especially 
those related with medical devices34, as flexible endoscopes. When biofilms are identified as the 
main cause of infection, treatment becomes very difficult since bacteria within biofilms adopt 
special features that confer them increased resistance to antimicrobial agents13. This resistance 
usually makes sessile microorganism more difficult to kill and remove from surfaces than 
planktonic counterparts. Furthermore, in many cases incomplete removal of the biofilm allows it 
to quickly return to its equilibrium state. 
In this work, some phenotypic characteristics (early-stage adhesion, biofilm formation ability and 
sensitivity to different antimicrobials) of P. aeruginosa isolated from an endoscope were 
inspected. 
The ability to adhere of the isolated strain was superior to that of wild-type strain as j0 and n30 are 
around two-fold higher than those observed for the reference strain. Besides revealing higher rate 
of adhesion (j0), the isolated strain also showed higher number of cells adhered to the surface after 
30 min of contact (Table 3.2-1). Furthermore, the strength of adhesion of this bacterium on PS 
surfaces was stronger as PBS circulation failed on cell detachment. In fact, for the reference strain 
the detachment of cells was around 20%, while for the isolated strain, no significant cell 
detachment was observed. Knowing that PAI was obtained from a real biofilm formed on an 
endoscope, it is conceivable to speculate that the isolated strain has been exposed to mechanical 
and chemical stress conditions, namely during endoscope reprocessing. So, as a survival strategy, 
this isolated strain may have acquired phenotypic and physicochemical changes that allowed it to 
adhere easily on PS and with superior strength. In fact, other authors2 reported that organisms 
isolated from any given niche, medical, environmental, or industrial, have different mechanisms of 
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adhesion and retention, mainly due to changes in their structural components, such pili, fimbriae, 
and adhesive surface proteins that have adapted differently over time through selective pressures. 
Furthermore, exposure to antimicrobials may as well induce changes in cell surface 
hydrophobicity and surface charge that can alter bacterial adhesion properties24. 
The prominence of PAI was also visible in terms of biofilm formation ability, as it has developed 
biofilms with more biomass, respiratory activity and number of cells than PA (Fig.3.2-1). This 
feature together with the greatest capacity to adhere allow to speculate that this isolated strain is 
more pathogenic than ATCC strain, as bacterial attachment and biofilm formation are considered 
important virulence factors of bacterial pathogens31,42. In fact, the formation of thick biofilms gives 
bacteria, amongst other advantages, protection from external aggressions, as host defences and 
antimicrobials, due to the lypopolysaccharides that constitute the EPS matrix8. This EPS matrix 
acts also as a diffusion barrier that can reduce antimicrobial efficacy by diminishing its penetration 
into the deeper layers of the biofilm. Protected within this niche, bacteria can detach, proliferate 
and furthermore disseminate in large amounts making possible the spread of pathogens16. 
Although the isolated strain develops thicker biofilms, it must be referred that luckily the capacity 
of both strains to develop biofilms was greatly impaired in the presence of antibiotics. The 
concentration of antibiotics used to cause antimicrobial stress (3 mg/L of CIP and 10 mg/L of GM) 
was similar to those referred in literature33 to have high bactericidal activity (16 x MIC or 3 x 
MBC), however it must be highlighted that a substantial number of viable cells remained adhered 
on PS surfaces. CIP is known for being initially very effective against P. aeruginosa. GM is also 
used to control P. aeruginosa growth and has been described in several works as a potential 
antibiotic to treat biofilm associated infections20,26,28. However, the diminished biofilm-forming 
capacity shown by PA and PAI under CIP and GM pressure may be related with other action than 
bactericidal activity. Biofilm formation by P. aeruginosa is hypothesized to follow a 
developmental pattern involving essentially four steps18: surface attachment, irreversible 
attachment, microcolony formation and differentiation into a mature population encased in a 
polymeric matrix. The presence of the antibiotics during biofilm formation may have interfered in 
the transition from reversible bindings to stable and irreversible interactions32, affecting the 
transition from microcolonies to biofilms and thus delaying the mature biofilm development15. 
With the cessation of the antibiotic pressure, those less dense biofilms resumed their 
developmental process and gave rise to thicker biofilms, being again the PAI biofilms superior to 
those formed by the wild-type strain. 
During endoscopy procedure, the external environment surrounding the medical device provides 
optimal conditions for microbial adhesion and biofilm growth10,21. If the disinfection procedures 
implemented during endoscopy reprocessing are not fully effective, biofilms may form and persist. 
These biofilms can later release bacterial cells that can spread to other locations, contaminating 
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new surfaces and infecting the patients that underwent endoscopy. A vicious circle of biofilm 
growth, antimicrobial treatment, partial killing or inhibition of some susceptible population and 
regrowth of resilient cells can thus be created. This vicious circle was clearly observed in Fig.3.2-
2, when biofilms obtained after the first period of PAE were submitted to a new cycle of antibiotic 
pressure being observed again, a decrease in their density and activity. The number of biofilm-
entrapped cells has also decreased but a substantial number of cells remained viable and adhered, 
mainly when GM was used. This latter event may be related with GM difficulties to diffuse across 
the biofilm matrix17, limiting thus its access to the biofilm-growing cells. To augment its efficacy 
it has been recommended in-use concentrations of GM higher than those used for other antibiotics. 
Conversely, ciprofloxacin is known for its ability to penetrate rapidly43. Based on these data, it can 
be concluded that both antibiotics have great ability to disrupt established biofilms but poor 
capacity to completely inhibit biofilm-growing bacteria. Furthermore, when the level of antibiotics 
dropped, in the PAE periods, the population of adhered cells was able to multiply and to 
repopulate the biofilm, as observed during the second recovery period when the remaining cells 
recovered biofilm mass and metabolism. 
This cycle of biofilm decrease/biofilm recovery may be explained by the existence, within the 
entire P. aeruginosa biofilm population, of a subpopulation of dormant cells that survive antibiotic 
treatment ensuring population survival. These cells that do not grow in the presence of an 
antibiotic, but neither do they die, are known as persister cells23. This subpopulation is recognized 
as “drug-tolerant” as they remain metabolically inactive in stressful conditions, but they can resort 
to normal growth rates and susceptibility in the absence of antibiotic. The data gathered in this 
study allows speculating that biofilm development in the presence of antibiotics can be 
problematic as antimicrobial pressure can select persister cells and encourage bacterial adhesion 
and biofilm development. This resilient sessile population, that is normally able to sustain an 
antimicrobial attack, can account for the prevalence of biofilm-associated infections and for 
recalcitrance of surface contamination23,30. 
The environmental pressure exerted by CIP and GM did not contribute to the development of P. 
aeruginosa tolerance to the same antibiotics. In fact, the 96-h-old biofilms developed only in TSB 
are practically tolerant to the toxic action of CIP and GM, however those biofilms formed under 
antibiotic selective pressure are to a certain extent susceptible to the same antibiotic attack. The 
sensitivity to the antibiotics of the biofilms formed by the isolated strain is similar to that 
displayed by the biofilms developed by the reference strain. Based on this evidence, it can be 
referred that the environmental stresses to which the isolated P. aeruginosa have been submitted 
during endoscope reprocessing did not caused the development of a resistant phenotype towards 
the antibiotics studied. It is accepted that antimicrobial selective pressure may result not only in 
selection of persister cells but also in the development of cross-resistance towards other 
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antimicrobials. In this study, data showed that BC was quite effective against P. aeruginosa 
biofilms, despite not having caused complete sanitation. All P. aeruginosa 96-h-old biofilms 
developed or not under antibiotic pressure were similarly susceptible to BC attack (Fig.3.2-3). 
These data highlighted that biofilm-growing bacteria subjected to CIP and GM pressure did not 
exhibited cross-resistance to benzalkonium chloride. The use of this cationic surfactant is not 
advised in endoscope washing procedures, but this product is still used in clinical practice for 
surface disinfection, antisepsis preservation and cleaning37. 
The exposure of cells within the biofilm to antibiotics pressure did not further promoted 
antimicrobial resistance to any of the antimicrobials tested (Fig.3.2-3). However, it must also be 
referred that none of the conditions caused complete sanitation of the biofilms, being, in general, 
the action of the antimicrobials more effective in bacteria inactivation than in biofilm removal. 
This fact is of upmost importance as cells may then detach from the remaining biofilms and 
disseminate infection elsewhere. 
The antimicrobial treatment of bacterial biofilms may lead to eradication of most of the susceptible 
or metabolically active population but again, the small fraction of persister cells or bacteria in the 
deeper biofilm layers that are just exposed to sub-inhibitory concentrations can survive and be able 
to reconstitute the biofilm after discontinuation of antimicrobial therapy8.  
Since biofilms do not develop or mature in stress conditions but rather maintain a remaining 
adhered population and are exceptionally complex to eradicate, are considered recalcitrant17. The 
persister cells give rise to a new diverse biofilm community with high genetic variability. This 
“new” biofilm is not as persistent as the cells that where in its foundation, being on the contrary as 
sensitive to external aggressions as a biofilm developed in normal conditions17. The persister cell 
role in biofilm survival will undoubtedly drive the effort to understand the mechanisms of their 
remarkable recalcitrance3. 
In this study, it was showed that the isolated endoscope strain possesses the ability to adhere in 
higher extent than the wild-type strain, developing after, thicker biofilms. Its increased ability to 
adhere may be due to its previous stress exposure to cleaning agents and disinfection procedures. 
Moreover, biofilm development in the presence of high doses of antibiotics might lead to the 
eradication of the most part of the biofilm population, selecting just a small fraction of persister 
cells, which can survive being able to reconstitute the biofilms following discontinuation of 
antibiotic therapy. This may represent an increased risk of infection to patients, requiring careful 
surveillance. As persister cells, that survive within the biofilm after treatments, can develop new 
biofilms and re-colonize other accessible sites, the anti-biofilm efficacy of a cleaning agent or 
antibiotic should not be just related with the reduction of biofilm mass or number of cells, but its 
success depends largely of its ability to kill all biofilm-cells, promoting the complete biofilm 
eradication from surfaces. 
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A STUDY ON THE EFFECTS OF ANTIMICROBIAL RESIDUES ON EARLY ADHESION AND 
BIOFILM FORMATION BY WILD-TYPE AND BC-ADAPTED STRAINS OF PSEUDOMONAS 
AERUGINOSA 
Antimicrobial residue deposition can change the physicochemical properties of bacteria and surfaces and 
thus promote or impair bacterial adhesion. This study focuses on benzalkonium chloride (BC) deposition on 
polystyrene (PS) surfaces and the influence of this conditioning film in PS physicochemical properties and 
on early adhesion and biofilm formation of Pseudomonas aeruginosa wild-type and its laboratory BC-
adapted strain. 
BC-adapted strain easily acquired ability to grow in BC, exhibiting also physicochemical changes in surface. 
The existence of residues on PS surfaces altered its hydrophobicity and favoured adhesion as determined by 
the free energy and early adhesion characterization. Adapted bacteria revealed higher ability to adhere and to 
develop biofilms especially on BC-conditioned surfaces, which thereby could enhance its resistance to 
sanitation. 
These findings highlight the importance of investigations concerning the antimicrobial deposition effect 
after cleaning procedures, which may encourage bacterial adhesion, especially of bacteria that have been 
exposed to chemical stresses. 
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4.1.1 INTRODUCTION 
Pseudomonas aeruginosa is an important opportunistic Gram-negative human pathogen14,16. This 
environmental bacterium is capable of living planktonically or in abiotic and biotic surface-
associated populations known as biofilms14,15. Biofilms are sessile microbial communities encased 
in matrices mainly composed of extracellular polymeric substances (EPS)14 that act as a scaffold, 
holding biofilm-cells together12 and protecting bacteria from external agressions4. 
Biofilm formation is a developmental process that involves essentially four main stages: i) 
bacterial deposition on a surface and irreversible adhesion, ii) formation of microcolonies, iii) 
maturation and iv) cell dispersion to the planktonic stage9. During the initial stage, the adhesive 
properties of bacterial cells cause irreversible attachment to a colonisable surface12, this process 
being mediated by biological, physical and chemical factors9. The attachment process is usually 
preceded by the formation of a conditioning film on a surface as a result of interactions between 
the substratum and the surrounding environment1,8. Surface conditioning can also occur, for 
example, after cleaning procedures, with the unintentional deposition of biocides residues on the 
surfaces. This unintentional surface conditioning can occur mainly by: i) the deplored practice of 
“topping-up” of biocide solutions without subsequent washing with water, ii) the incorrect use of 
biocides and incorrect concentrations, iii) the use of a biocide that is not appropriate for a certain 
type of surface and iv) pre-cleaning errors, for example, the residues of several products can 
interfere with the activity of each other20,23. Once a surface has been conditioned, its properties 
become permanently altered, so the affinity of an organism for a native or a conditioned surface 
can vary greatly depending on the molecules in the conditioning film7,18. After adhesion, biofilm 
formation takes place by auto-aggregation of the attached cells and formation of microcolonies9. 
Once a biofilm is established and matured, EPS are produced12 creating a three-dimensional 
structure within the biofilm community9. The last stage in biofilm formation involves cell 
detachment, which is an active dispersion of cells from the biofilm matrix9. 
Evidence suggest that adhesion to surfaces and subsequent biofilm development are linked to the 
persistence and virulence of P. aeruginosa12, contributing to the increased resistance of this 
bacterium to antimicrobial agents14,21. Altered cell phenotypes with different sensitivities to 
biocides can be the result of three types of bacterial resistance: i) intrinsic (or innate) to the 
microorganism, ii) adapted resistance that results from the continuous exposure to certain 
environmental conditions, such as antimicrobial compounds, or due to epigenetic phenomena like 
persistence and iii) acquired due to the forced mutations or through the acquisition of mobile 
genetic elements11. P. aeruginosa has long been regarded as an organism that easily adapts to 
quaternary ammonium compounds (QACs)10. QACs are bacteriostatic at low concentrations and 
bactericidal at high concentrations. Thus, at low concentrations, this agent may favour the 
development of adaptive resistance. Various mechanisms have been reported to play, either singly 
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or synergistically, roles in bacterial adaptive responses to antimicrobials. These adaptive 
mechanisms can include alterations: i) in outer membrane proteins, ii) antimicrobial uptake, iii) 
cell surface charge and hydrophobicity, and iv) fatty acid content of the cytoplasmatic 
membrane13. However, microorganisms may have multiple, possibly interconnected, adaptive 
mechanisms depending on the nature of the antimicrobial agent.  
The aim of this work was to study the role of surface conditioning with benzalkonium chloride 
(BC) on early-stage adhesion and the biofilm formation ability of two P. aeruginosa strains (wild-
type and a laboratory BC-adapted strain). The physicochemical properties of clean and BC-
conditioned polystyrene surfaces (PS) and of non-adapted and BC-adapted P. aeruginosa strains 
were also evaluated. 
4.1.2 MATERIALS AND METHODS 
Strain and culture conditions  
P. aeruginosa (ATCC 10145) and BC-adapted P. aeruginosa were used throughout this work 
Antibacterial Agent 
Benzalkonium chloride (BC) was used. 
Induction of BC adaptive resistance in P. aeruginosa  
BC adaptive resistance was laboratory induced in P. aeruginosa wild-type strain as described in 
sub-chapter 2.2.2 to further evaluate the role of this step on the physicochemical properties of the 
cell surface, early adhesion and biofilm forming ability. 
Growth kinetics 
The potential adaptive resistance of the BC-adapted P. aeruginosa was checked by bacterial 
growth in the presence of increasing concentrations of BC, as described in sub-chapter 2.2.3. 
Surfaces conditioning 
In order to examine the effect of BC residues in the thermodynamic prediction of adhesion, and on 
early bacterial adhesion and biofilm formation, several PS surfaces of different sizes, were 
conditioned through random deposition of BC residues, as described in sub-chapter 2.3.1. 
Physicochemical characterization of surfaces and cells  
In order to investigate the physicochemical properties for P. aeruginosa wild-type and BC-adapted 
cells and PS surface, the contact angles and hydrophobicity were determined for both bacteria and 
clean and BC-conditioned surfaces, following the van Oss et al. approach27, according to the 
procedure described in sub-chapter 2.3.2.  
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Early bacterial adhesion 
A parallel plate flow chamber (PPFC) and an image analysis system were employed to study 
early-stage bacterial adhesion and detachment, as described by Sjollema et al.22 according to 
procedure described in sub-chapter 2.3.3. 
 
Biofilm formation 
The biofilm forming ability of wild-type and BC-adapted P. aeruginosa on clean and BC-
conditioned surfaces was assessed using the microtiter plate test developed by Stepanovic et al.24 
as described in sub-chapter 2.4.1. Periodically, i.e., after 2, 4, 6 and 24 h of biofilm growth, the 
content of each well was removed and the biofilms were washed twice with 200 μL of sterilized 
UP water being reserved for analysis. Each experiment was performed in five independent assays. 
Biofilm analyses 
Biofilm mass of both P. aeruginosa strains was quantified by the crystal violet (CV) staining 
method, adapted from Stepanovic et al.24. Biofilm activity was evaluated using the 2,3-bis (2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide sodium salt (XTT) colorimetric 
method, as described by Stevens and Olsen25. Both procedures are described in detail in sub-
chapter 2.4.4.2 and 2.4.4.3. 
 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism, version 4.0 software for Macintosh. 
Normality of data distribution was tested by the Kolmogorov-Smirnov method. Statistical 
significance values of the groups’ means of i) contact angles, ii) biofilm mass, and iii) biofilm 
activity were evaluated using a one-way analysis of variance. Subsequent comparisons were 
performed using Tukey’s post-hoc test. The statistical analyses performed were considered 
significant when p<0.05. 
 
4.1.3 RESULTS 
Growth kinetics 
In order to assess the growth behaviour of P. aeruginosa wild-type and BC-adapted strains, and to 
establish the minimum inhibitory concentration (MIC), bacterial growth in the presence of several 
concentrations of BC was followed over time. Fig.4.1-1 shows that in the absence of BC both 
strains exhibited similarly patterns of growth. However, in the presence of BC significant 
differences in the bacterial growth curves were detected. Fig.4.1-1 A shows that complete growth 
inhibition was only detected for the wild-type strain, at a BC concentration > 1.5 mM. However, 
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concentrations between 0.8 mM and 1.5 mM of BC disturbed the growth pattern of P. aeruginosa 
wild-type cells. Even the lower concentration tested (0.3 mM) promoted the extension of the 
latency phase in comparison with growth in the absence of BC (Fig.4.1-1 A). 
 
Fig.4.1-1 Growth kinetics of P. aeruginosa wild-type strain (A) and BC-adapted P. 
aeruginosa (B), in the absence () and presence of different concentrations of 
benzalkonium chloride (BC): () 0.3 mM, () 0.5 mM, () 0.8 mM, () 1.2 mM, () 
1.5 mM, () 2.0 mM, () 2.5 mM, () 3.0 mM.  
The BC-adapted strain exhibited growth patterns in the presence of BC significantly different from 
those of P. aeruginosa wild-type (Fig.4.1-1 B). The adapted strain was able to survive and grow in 
the presence of all the concentrations tested, although OD640 values were lower than the observed 
in the absence of BC. However, an increase in the lag phase was observed for all the BC 
concentrations tested. 
These data indicated that the laboratory adaption process of P. aeruginosa to BC gave rise to a 
strain with significant physiological changes, mainly in response to antimicrobial stress induced by 
BC.  
Prediction of adhesion  
The evaluation of the hydrophobicity parameters for the wild-type and BC-adapted strains and the 
clean and BC-conditioned surfaces are shown in Table 4.1-1. 
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Table 4.1-1 Values of contact angles (°) with water (θW), formamide (θF), α-bromonaphtalene (θB), surface tension 
parameters (mJ/m2), and free energy of interaction (∆𝐺!"!!"!) (mJ/m2), of the bacteria and the surface (i), when immersed 
in water (w). Values are means ± SD.  
 Contact angle (°) 
Surface tension parameters 
(mJ/m2) 
Free energy of 
interaction 
(mJ/m2) 
 θW θF θB γiAB γi+ γi- ∆𝐺!"!!"!  
P. aeruginosa wild-type 29.0 ± 5.3 26.3 ± 2.1 78.0 ± 3.0 16.2 10.0 44.1 11.2 
P. aeruginosa adapted strain 30.7 ± 4.0 30.9 ± 2.6 58.4 ± 4.8 25.8 3.6 46.6 22.1 
Clean surface 90.9 ± 4.0 73.3 ± 3.5 26.4 ± 1.0 40.0 0.7 4.4 -55.2 
BC-conditioned surface 103.0±14.3 69.9 ± 9.5 29.5 ± 8.6 40.0 0.2 0.1 -94.2 
The results indicate that the contact angle formed by the cell layer and water (θw) was similar for 
both strains (p>0.05) and lower than 65 º. These data mean that the P. aeruginosa wild-type and its 
adapted strain can be classified, from a thermodynamic point of view, as hydrophilic. Concerning 
the free energy of interaction of both strains (∆𝐺!"!!"!), calculated through Equation (1), an increase 
of this parameter for the BC-adapted strain was observed (Table 4.1-1). 
PS surfaces can be considered hydrophobic since the water contact angle values (θw) of the 
material were higher than 65 º. When surfaces were conditioned with BC residues, their 
thermodynamic properties were altered. This is clearly shown in terms of the free energy of 
interaction (∆𝐺!"!!"!) since the difference between clean and BC-conditioned surfaces is about 40 
mJ/m2 (Table 4.1-1). This means that, theoretically, the affinity of an organism for the BC-
conditioned surface is superior when compared to the clean surface. 
The physicochemical parameters of each adhesion entity (bacteria and surface) allowed the 
determination of the thermodynamic relation between both entities, namely the free energy of 
adhesion (Table 4.1-2). 
Table 4.1-2 Free energy of adhesion (∆𝐺!"!!"!),  between the bacteria (b) and the surfaces (s)  
 Free energy of adhesion (mJ/m2) 
 (∆𝐺!"!!"!) 
 Clean Surface BC-Conditioned Surface 
P. aeruginosa wild-type 4.4 -4.2 
P. aeruginosa adapted strain -5.0 -15.1 
These data (Table 4.1-2) suggest that, when the surfaces are not conditioned with BC, the initial 
adhesion is favoured for the BC-adapted strain vs wild-type, as indicated by the more negative 
value of free energy of interaction. Table 4.1-2 also highlights that the conditioning of the surfaces 
with BC residues thermodynamically favoured the initial adhesion of both strains, since reductions 
in the free energy of interaction from 4.0 to -4.2 mJ/m2, for the wild-type strain, and from -5 to -
15 mJ/m2, for the BC-adapted strain, were observed. 
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Early stage bacterial adhesion 
The PPFC assays revealed that the initial adhesion patterns differ according to the strain and the 
conditioning of the surface (Fig.4.1-2). The early adhesion profile of the BC-adapted P. 
aeruginosa revealed that this strain had a slower start in its adhesion to PS (up to around 350 s), 
which was followed by a period of higher cellular adhesion in comparison with the wild-type 
strain. After the adhesion period (1800 s), the number of adapted-cells adhered to clean and BC-
conditioned PS was higher than for the wild-type strain (p<0.05). 
 
Fig.4.1-2 Adhesion profiles of P. aeruginosa wild-type () BC-adapted strain () on 
clean (open symbols) and BC-conditioned (filled symbols) surfaces. 
Concerning the influence of surface conditioning in this assay, the BC deposition on the PS 
surface enhanced bacterial adhesion, for both strains tested (Fig.4.1-2). The number of adhered 
bacteria was higher on the conditioned surfaces, this being more evident for the wild-type strain. 
The detachment stage (circulation of PBS between 1800 s and 3600 s) (Fig.4.1-2), revealed that 
the BC-adapted strain was more able to establish a firm adhesion on the surface, since the number 
of adapted-cells adhered to PS was higher than the number of wild-type adhered bacteria, 
irrespective of which surface was used.  
Concerning the influence of the surface conditioning in this assay, the BC residue deposition on 
the PS surface enhanced bacterial adhesion, for both strains tested (Fig.4.1-2). In fact, the number 
of adhered bacteria was higher in the conditioned surface, being this more evident for the wild-
type strain. 
Biofilm formation 
The evolution of the biomass and activity of biofilms formed by the wild-type and BC-adapted P. 
aeruginosa over time on clean and BC-conditioned surfaces are shown in Fig.4.1-3 
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Fig.4.1-3 Biofilm mass (OD570) (A), and metabolic activity (OD490) (B) of biofilms developed for 2, 4, 6 
and 24 h, in clean and BC-conditioned surfaces by P. aeruginosa wild-type (white), and BC-adapted strain 
(grey). Bars are mean (± SD) of eight replicates obtained on five independent experiments. 
Fig.4.1-3 A shows that, in general, the amount of biofilm mass accumulated on the surfaces 
increases until the sixth hour of biofilm formation. On clean surfaces, the wild-type strain 
developed thicker biofilms than those formed by the BC-adapted strain. Concerning the influence 
of BC residues deposition on biofilm development, higher biomass accumulation was observed for 
biofilms developed by both strains on BC-conditioned surfaces when compared with biofilms 
developed on clean surfaces (p<0.01). 
Data related with biofilm activity (Fig.4.1-3B) show that, for both surfaces, no significant 
differences were observed between strains (p>0.05). Regarding the effect of BC residues on 
biofilm activity, the presence of the conditioning film, only influenced biofilm formation at 24 h. 
At this time point, biofilms developed on the conditioned surfaces revealed higher values of 
biofilm activity than biofilms developed on the clean surfaces (p<0.01). 
4.1. 4 DISCUSSION 
Antimicrobial residues deposition can alter surface physicochemical properties and thus interfere 
with bacterial adhesion. In this work, PS surfaces were conditioned with a BC solution and the 
changes on the surface physicochemical properties, as well as their implication in adhesion ability 
and biofilm formation by P. aeruginosa wild-type and BC-adapted strain were investigated. 
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Moreover, the surface hydrophobicity of P. aeruginosa wild-type and its laboratory-adapted strain 
was also assessed. 
The differences observed in the growth curves of the BC-adapted strain indicated that this strain 
acquired traits of adaptive resistance, since none of the BC concentrations tested were able to 
prevent bacterial growth (Fig.4.1-1 B). The continuous exposure of P. aeruginosa to BC gave the 
strain the ability to persist and grow at high BC concentrations. Table 4.1-1 shows that BC-
adaption induced changes in bacterial surface hydrophobicity and that the deposition of BC 
residues modified the PS surfaces giving rise to surfaces more prone to promoting adhesion. The 
analysis of the free energy of adhesion between strains and surfaces (Table 4.1-2) suggested that, 
in theory, adhesion of both strains was favoured on conditioned surfaces, the strength of adhesion 
being higher for the BC-adapted strain when compared with the wild-type. These data reinforce 
the conclusion that the thermodynamic properties play a key role in initial bacterial adhesion to 
surfaces, as indicated by previous work3. Based on these results, it can be inferred that adhesion 
depends most on the properties of the conditioning film rather than on the surface itself1,19. 
Concerning early adhesion, deposition of BC residues on the adhesion surfaces promoted an 
increase in the number of adhered bacteria (Fig.4.1-2). Similar features were also noticed by other 
authors that observed a higher number of adhered bacteria when surfaces were conditioned with 
blood18, gold2 and biosurfactants17. Another study26 reported that BC-impregnated catheters 
exhibited reduced microbial colonization by several microorganisms, suggesting that the BC 
conditioning film may prevent colonization. In the present study, the experimental conditions used 
to promote the surface conditioning (t=30 min and 0.9 mM of BC) were clearly not enough to 
change its properties so they become less prone to bacterial adhesion. Therefore, P. aeruginosa 
adhesion on the modified surfaces could not be impaired, especially when the bacterium was 
previously adapted to BC. It is thought that BC acts on the properties of cell wall as well as on the 
outer membrane of Gram-negative bacteria. According to Gilbert and Moore6, BC molecules are 
positively charged and bind strongly to bacterial surface, changing their native negative charge. In 
this study, as bacteria grew during the step-wise adaptation process in the presence of increasing 
BC concentrations, changes in the cell wall or of the outer membrane of P. aeruginosa cells could 
have occurred and may explain the alteration in the free energy of interaction of the BC-adapted 
bacteria (Table 4.1-1) and, subsequently, the free energy of adhesion to the PS surfaces (Table 4.1-
2). 
The formation of a conditioning film and the adhesion of bacteria to a surface are the first two 
steps of the biofilm developmental cycle5. To seek the role of these events in the sequential steps 
of biofilm formation by P. aeruginosa wild-type and its adapted strain, in this study, biofilms were 
developed for different time periods (2, 4, 6 and 24 h) (Fig.4.1-3). For all the periods of biofilm 
development and with the preconditioning conditions tested, the presence of residues on the 
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surfaces favoured biofilm phenotype since for both strains it promoted biofilm mass accumulation 
(Fig.4.1-3 A). Other authors19, when studying the ability of P. fluorescens to adhere to silicone 
rubber, also observed an increase in biomass accumulation on BC conditioned surfaces. The 
preconditioning of the silicone surfaces was also carried out for 30 min19. In the same study, the 
biofilm biomass increased gradually with the increase in the BC concentration used in the 
preconditioning, 0.5 mM being the highest concentration tested. 
The P. aeruginosa adapted strain was shown to have more ability to adhere regardless of whether 
the surfaces were preconditioned or not. The adsorption of BC residues on PS surfaces seems to 
favour biomass accumulation by this strain when compared with biofilms formed by the wild-type 
strain (Fig.4.1-3). The study of the BC-adapted strain was performed in order to highlight the fact 
that special care should be taken with antimicrobial and disinfection experiments that use only 
reference strains. Bacteria, in real situations, are permanently exposed to external factors and thus, 
may exhibit different phenotypic traits that can alter their behaviour and response to the action of 
antimicrobials. 
This study gives new insights into the significance of the conditioning film, not only in early 
adhesion events, but also in the development of biofilms, even when the effect of the antimicrobial 
was thought to be masked by the surrounding environmental conditions. 
In conclusion, the results show that deposition of BC residues can support changes in the 
thermodynamic properties of surfaces and enhance bacterial adhesion and even favour biofilm 
formation, mainly by the BC-adapted bacteria. These features may explain the increased resistance 
and virulence often observed in P. aeruginosa strains in real-life scenarios. Therefore, in order to 
avoid bacterial outbreaks and disinfection practice failures, special care should be taken with the 
design of effective sanitation programs and antimicrobial residues accumulation should be 
avoided. 
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CHAPTER 4.2 
 
 
ADAPTIVE RESPONSE OF SINGLE AND BINARY PSEUDOMONAS AERUGINOSA 
AND ESCHERICHIA COLI BIOFILMS TO BENZALKONIUM CHLORIDE 
The main goal of this work was to examine whether the continuous exposure of single and binary 
Pseudomonas aeruginosa and Escherichia coli biofilms to sub-lethal benzalkonium chloride (BC) doses can 
induce adaptive response of bacteria. 
Biofilms were formed during 24 h and then put continuously in contact with BC for more five days. The six-
day-old adapted biofilms were then submitted to BC challenge, characterized and inspected by Scanning 
Electron Microscopy (SEM).  
Both single and binary adapted biofilms have clearly more biomass, polysaccharides and proteins and less 
activity even though the number of cells was identical. After BC treatment, adapted biofilms maintained 
their mass and activity. SEM examination revealed that those adapted biofilms had a slimier and denser 
matrix that became thicker after BC treatment. 
Continuous exposure of bacteria to antimicrobials can lead to development of biofilms encompassing more 
virulent and tolerant bacteria. This adaptive resistance can be the result of a phenotypic adaptation, a genetic 
acquired resistance or both. 
Instead of eradicating biofilms and kill microorganisms, the use of a disinfectant can favour biofilm 
formation and tolerance. This must be a genuine concern as it can happen in clinical environments, where 
the use of antimicrobials is unavoidable. 
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4.2.1 INTRODUCTION 
Pseudomonas aeruginosa and Escherichia coli are two of the most important human associated 
pathogens and commensal bacteria24 that can contaminate inanimate surfaces during months, 
specially when attached and developing biofilms10. Both bacteria show an increase in 
pathogenicity due to their motility structures (type IV pili in P. aeruginosa and curli in E. coli) and 
matrix production through extracellular polymeric substances (EPS) secretion. Previous 
works11,12,16,33 showed that EPS synthesis (alginate for P. aeruginosa and colanic acid in E. coli) is 
induced upon attachment of the bacteria to a surface. 
Usually, the procedures for surface cleaning involve the use of detergents followed by application 
of disinfectants that reduce the viability of microorganisms49. Antimicrobials, as quaternary 
ammonium compounds (QAC), have been continuously used in hospitals and healthcare facilities, 
and have significantly contributed to maintain sanitary conditions and to prevent hospital-acquired 
infections. Despite their valuable properties, concerns have been raised about the widespread and 
irrational use of disinfectants that could fail the eradication of the biofilm-associated 
microorganisms and serve to select disinfectant-insusceptible microbes among hospital-acquired 
pathogens8,22,34,41.  
Physiologic or phenotypic adaptation resulting in “antimicrobial tolerance” has been attributed to 
biofilms17,42. Biofilm tolerance to disinfectants may result from (i) slow microbial growth rates that 
are attributable to nutrient depletion within biofilms, (ii) binding of the biocide to the EPS, (iii) 
neutralization or degradation of the biocide, as well as (iv) the expression of biofilm-specific 
phenotypes10,42,47. Evidence suggest that proteins involved in oxidative stress response, cell 
envelope synthesis, and EPS synthesis are up-regulated in biofilms, indicating that these altered 
phenotypes might contribute to cell survival, persistence, and growth in a biofilm community32,39. 
Moreover, biofilms usually comprise more than one microbial species, and can harbour strains 
with less ability to develop a biofilm, contributing to their survival and persistence. It has been 
reported that two bacteria present in an in vitro binary biofilm may live synergistically and 
enhance each other survival to antimicrobial treatments compared with the corresponding single 
species biofilms28. An important aspect of the study of the interactions in multispecies biofilms is 
to evaluate whether individual species, or the bacterial consortium, gain any fitness advantages 
compared to single-species biofilms. A fitness advantage in this context is defined as the ability of 
the organism or biofilm to persist or grow in a given environment or under a particular 
environmental stress. Multiple species biofilms may be thicker and more stable than the single 
ones, which may influence their susceptibility to disinfectants6. 
The aim of this work was to examine whether exposure of P. aeruginosa and E. coli to 
benzalkonium chloride (BC) during single and binary biofilm formation, could induce an adaptive 
response in bacteria by evaluating the biofilms behaviour after treatment with the same agent. BC 
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is a well-known QAC that has been widely used as surface disinfectant, antiseptic and preservative 
in medical arenas. Considering the intense use of BC as an antimicrobial agent, it is important to 
increase the knowledge about the effects of external chemical pressure and polimicrobial growth 
on the susceptibility of the sessile target organisms to this QAC. 
4.2.2 MATERIALS AND METHODS  
Strain and culture conditions  
Pseudomonas aeruginosa ATCC 10145 and Escherichia coli K12 substrain MG 1655 were used. 
Antibacterial Agent 
Benzalkonium Chloride (BC) was used throughout this work. 
Determination of minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) 
The BC MIC and MBC of P. aeruginosa and E. coli were determined by the microdilution method 
according to Clinical and Laboratory Standards Institute (formerly National Committee for 
Clinical Laboratory Standards)35, as described in sub-chapter 2.2.1. 
Biofilm development and adaptation 
The methodology used to grow the bacterial biofilms was based on the microtiter plate test 
developed by Stepanovic et al.45 as described in sub-chapter 2.4.1.3. 
After 24 h of biofilm growth, the supernatant containing planktonic cells and medium was 
removed. The wells were re-filed with fresh TSB or TSB containing BC in a final concentration of 
0.9 mM to mimic external BC chemical pressure in order to induce the adaptation of the biofilm-
embedded cells. This process of supernatant removal and media filling was repeated for five 
subsequent days, every 24 h. The six-day-old biofilms formed in TSB supplemented with BC are 
hereafter referred as adapted biofilms while the biofilms formed only in TSB will be referred as 
normal biofilms. 
Biofilm treatment with BC 
After being developed in the absence and presence of BC for six days (during the adaptation 
process), biofilms were subjected subsequently to sudden attack with the same antimicrobial 
product. For that, the liquid content of each well was removed and washed once with 200 μL of 
UP sterilized water, being the well-attached biofilms (biofilms formed by P. aeruginosa and E. 
coli in the inner surfaces of each well of the microtiter plates) subsequently treated with 200 μL of 
1.0 mM of BC for 30 min. This procedure had the major purpose of eliminating more susceptible 
and outward biofilm-cells. Non-treated wells were filled with 200 μL of UP sterilized water for the 
same period of time. After that, the content of each well was removed and biofilms were washed 
twice with 200 μL with UP sterilized water and reserved for subsequent analysis (see below). 
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Bacterial suspensions of the single and binary P. aeruginosa and E. coli non- and adapted biofilms 
to be used in protein and polysaccharide quantification and cfu determination were prepared as 
described hereafter. Two-hundred microliters of UP sterilized water were added to each well, 
being the wells-attached biofilms removed by ultrasonic bath in a Sonicor SC-52 (Sonicor 
Instruments, Copaique, NY, USA) operating at 50 kHz, during 6 min (these parameters were 
previously optimized in order to promote the complete removal of all the biofilm-attached cells 
without lysis). Afterwards, the single and mixed bacterial suspensions of each five wells per 
condition were collected, gently vortexed for 2 min3,23,50 to disrupt possible cell aggregates, and 
reserved for later analysis. 
Biofilm analyses 
Biofilm mass determination 
Biomass of P. aeruginosa, E. coli and binary biofilms were quantified by crystal violet (CV) 
staining method adapted from Stepanovic et al.45 according to the procedure described in sub-
chapter 2.4.4.2. 
Biofilm activity determination 
Biofilm activity determination was evaluated with 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide sodium salt (XTT) colorimetric method as described by Stevens and 
Olsen46,  as described in 2.4.4.3. 
Biofilm cell enumeration 
Untreated and BC treated axenic and binary biofilm suspensions removed by sonication were 
serially diluted and the cfu determined according to the procedure described in sub-chapter 2.4.4.4. 
Proteins and polysaccharide quantification 
The total content of proteins and the total polysaccharides content of the single and mixed 
suspensions from normal and adapted biofilms, untreated and treated with BC, were determined 
according to the procedure described in sub-chapter 2.4.4.5. 
Scanning electron microscopy (SEM) observations  
The wells-attached washed biofilms were observed through SEM according to the procedure 
described in sub-chapter 2.4.4.1. 
Statistical analysis 
Statistical analysis was performed using GraphPad Prism, version 4.0 software for Macintosh. 
Normality of data distribution was tested by the Kolmogorov-Smirnov method. Statistical 
significance values of the groups’ means of biofilm mass, biofilm activity, cell number, protein 
and polysaccharide content were evaluated using a one-way analysis of variance. Subsequent 
comparisons were performed using Tukey’s post-hoc test. The statistical analyses performed were 
considered significant when p <0.05. 
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4.2.3 RESULTS 
Determination of MIC and MBC 
The MIC and MBC of planktonic P. aeruginosa and E. coli are shown in Table 4.2-1. P. 
aeruginosa revealed the highest MIC and MBC values when compared with those obtained for E. 
coli. To promote a selective BC pressure on the growth of both strains, a BC concentration of 0.9 
mM was chosen for the biofilm adaptation process. 
Table 4.2-1 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of BC 
against P. aeruginosa and E. coli 
 MIC (mM) MBC (mM) 
P. aeruginosa 0.45  0.90 
E. coli 0.23  0.23 
 
Biofilm analyses 
Biofilm mass 
In order to determine the biofilm formation ability of P. aeruginosa, E. coli and its binary 
combination, in the absence (normal biofilms) and in the presence of 0.9 mM of BC (adapted 
biofilms), the total biomass was determined. Fig.4.2-1 A shows that the six-day-old biofilms 
formed by single species and by the combination of both species in TSB had similar biomass 
values. The posterior treatment with 1.0 mM of BC did not alter the biofilm mass accumulated on 
the surfaces (p>0.05). 
It was also observed that both single and binary six-day-old adapted biofilms have clearly more 
biomass (p<0.001), about five times more, than the normal biofilms formed in the absence of BC. 
Fig.4.2-1 A also reveals that E. coli adapted biofilms exhibited more mass than those of P. 
aeruginosa (p<0.01) and than binary biofilms (p<0.05). Furthermore, posterior BC treatment 
seems to reduce the mass of P. aeruginosa adapted biofilms (p<0.05) and to increase the biomass 
of the binary biofilms (p<0.001).  
Biofilm activity 
The metabolic activity of the viable biofilm-entrapped cells is presented in Fig.4.2-1 B. P. 
aeruginosa cells of normal biofilms revealed an increased activity in comparison with that of 
adapted biofilm-entrapped bacteria (p<0.001). Data also showed that both single and binary 
adapted biofilms have less activity than those formed in the absence of BC (p<0.01). Among the 
adapted biofilms, binary biofilms presented the highest cell activity and P. aeruginosa biofilms the 
lowest (p<0.001). Concerning biofilm treatment with BC, the activity of the biofilm-associated 
cells was significantly reduced (p<0.001) in normal biofilms. Furthermore the six-days old P. 
aeruginosa biofilms developed in the presence of BC, when challenged with the same product, 
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revealed even more activity than the biofilms without treatment (p<0.001). Adapted binary 
biofilms and E. coli biofilms did not exhibit major changes in their activity upon QAC treatment 
(p>0.05). 
A 
 
B 
 
 
C 
 
Fig.4.2-1 Biofilm mass (OD570) (A), metabolic activity (OD490) (B) and number of cultivable cells (C) of single and 
binary six-day-old P. aeruginosa and E. coli biofilms developed in TSB (white bars) and TSB supplemented with 0.9 
mM of BC (grey bars). Biofilms were after treated with 1.0 mM BC (striped bars), non-treated biofilms (solid bars). 
Bars represent the average of 3 independent repeats ± SD. 
 
Biofilm-entrapped cells 
Concerning the number of biofilm-associated cells, after six days of biofilm growth (Fig.4.2-1 C), 
it was observed that the adaptation to BC, both for single and binary biofilms, seemed not to have 
influence on the number of total cells. In fact, the total number of cells entrapped in the biofilms 
was similar (approximately 107 cfu/cm2), whether adapted or not to BC. Furthermore, BC 
treatment of single P. aeruginosa and binary normal biofilms led to a 3 log reduction (p<0.001) in 
cell number whereas E. coli biofilm-entrapped cells just suffered a reduction of about 1 log. 
The effect of BC treatment on adapted biofilms was similar to the one observed in the normal 
biofilms as it also led to a decrease of about 3 log (p<0.001) in the number of biofilm-entrapped 
cells. 
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Biochemical biofilm characterization  
As the data showed that adaptation to BC seems to promote an increase in biomass values 
(Fig.4.2-1 A), it was considered pertinent to inspect the biochemical features of all biofilms. 
According to Fig.4.2-2, P. aeruginosa normal biofilms exhibit more protein content when 
compared to the other biofilms (E. coli and binary) (p<0.001). However, when the biofilms were 
adapted to BC, E. coli biofilms were those that revealed the highest protein content (p<0.001). The 
presence of BC during biofilm development led to biofilms characterized by 4-fold higher protein 
content, for P. aeruginosa and binary biofilms, and 8-fold higher for E. coli biofilms. 
A 
 
B 
 Fig.4.2-2 Biochemical biofilm characterization. Values of protein (A) and polysaccharide (B) content for of single 
and binary six-day-old P. aeruginosa and E. coli biofilms developed in TSB (white bars) and TSB supplemented 
with 0.9 mM of BC (grey bars). Biofilms were after treated with 1.0 mM BC (striped bars), non-treated biofilms 
(solid bars). Bars represent the average of 3 independent repeats ± SD. 
 
After BC challenge, normal biofilms did not show great variability in their protein content 
(Fig.4.2-2 A). Concerning BC-adapted biofilms, the treatment with 1.0 mM of BC promoted a 
reduction of about 50% of the protein content for P. aeruginosa and binary biofilms while for E. 
coli biofilms this reduction was just about 20 %. 
The amount of polysaccharides in normal biofilms was similar for all the strains (Fig.4.2-2 B). The 
presence of BC during biofilm development led to a significant increase of polysaccharide content, 
being about 10 times superior in P. aeruginosa and binary biofilms, and about 13 times superior in 
the case of E. coli. 
The BC treatment promoted an augment in polysaccharide content of P. aeruginosa biofilms 
(p<0.01) while no significant change was observed for E. coli and binary biofilms (p>0.05), when 
developed only in TSB. The BC challenge after biofilm adaptation to the same product promoted a 
significant decrease in the polysaccharide content, similar to that obtained for protein content. 
SEM observations  
The influence of BC, on biofilm superficial structure and morphology was assessed by SEM 
inspection (Fig.4.2-3). SEM observations revealed a morphological alteration induced by the 
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presence of BC during biofilm formation. The images of the BC-adapted biofilms surface seem to 
indicate a larger amount of EPS, especially for P. aeruginosa and E. coli single-species biofilm. 
 
Fig.4.2-3 SEM analysis of single and binary six-day-old P. aeruginosa and E. coli 
biofilms developed in TSB and TSB supplemented with 0.9 mM of BC (TSB + BC) 
without and with 1.0 mM BC treatment. X 10 000 magnification, bar=2.0 μm. 
The BC treatment after biofilm formation has different effects depending on the biofilms being 
adapted to BC or not. For biofilms formed in TSB, BC appears to cause some damages in the EPS 
matrix protecting biofilms. This matrix disruption is well noticed in E. coli and binary biofilms. 
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For BC-adapted biofilms, the images suggest that the subsequent BC challenge strengthens the 
existing matrix, giving the biofilm-entrapped cells an interconnected structure. 
4.2.4 DISCUSSION 
P. aeruginosa and E. coli are two human pathogens and commensal organisms often related with 
foreign body infections, mainly due to their ability to form biofilms. It is widely held that a biofilm 
represents a highly selective micro-niche where pathogens may also have high mutation rates or 
easily exchange genetic material, thus facilitating the development of antimicrobial drug 
resistance36. 
The continuous and, sometimes, inappropriate use of antimicrobials in several settings 
(households, hospitals and other institutions), together with the increased use of antibiotics to cure 
everyday diseases has been on the basis of selection of resistant bacteria. Moreover, the well-
known biofilm microniche properties and their intrinsic resistance to antimicrobial products due to 
their specific features, namely, EPS matrix protective barrier, nutrient and oxygen gradients, cell-
cell signalling, persister cells and genetic diversity, play a key-role in this easily acquired 
resistance. The planktonic bacterial adaptation to BC is a well documented subject1,4,21,29 and, 
recently, there have been some studies reporting biofilm adaptation to BC sub-MIC7,31,32,40,43. From 
the analyses of the latter studies, it was observed that the BC concentrations used for biofilm 
adaptation are not always the same, albeit being always lower than the MIC concentration 
determined. The adaptation method used to induce an adaptive tolerance of the biofilm-entrapped 
cells is not standardized, varying among authors, microorganisms and studies. 
In the present work, the adaptation of the P. aeruginosa and E. coli bacteria embedded in sessile 
life-style was attained at a BC concentration of 0.9 mM. It was not our objective to characterize 
which phenomenon (recalcitrance or resistance) was involved, but to study the biofilm phenotype 
after exposure to chemical stress conditions. The BC concentration used is higher than the ones 
used to adapt Salmonela (0.29 mM)31,32 within biofilms and Listeria planktonic cells (0.012 mM)40. 
Despite being the highest MBC determined for the most resistant strain (P. aeruginosa), the 
concentration of 0.9 mM was used to promote the BC pressure. Results showed that the presence 
of this BC concentration in the liquid environment surrounding biofilms did not impair their 
growth or caused cell death within the biofilms, since no reduction of the absorbance related with 
biomass (Fig.4.2-2 A) or decrease in cell number (Fig.4.2-2 C) was observed. These data are not 
surprising since it is widely accepted that cells entrapped in biofilms easily gain tolerance to 
antimicrobials. Normally, this insusceptibility is overcome with the use of supra-minimum 
inhibitory concentrations (supra-MIC) to ensure sanitation. The unexpected result of this study is 
the significant increase of biofilm mass due to BC pressure (5-fold higher) regardless the strain or 
the number of strains that generate the biofilm (Fig.4.2-1 A). These results show how the 
inappropriate use of an antimicrobial can favour bacteria attachment and biofilm formation, 
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instead of eradicating biofilms and kill microorganisms. In fact, in real situations, this can be a 
genuine concern as it can happen in clinical settings or apparatus, where the use of antimicrobials 
is unavoidable, as reported by Lee et al.26 in liquid reservoirs where antimicrobials are kept. 
The BC-adapted biofilms showed an increase in biofilm mass (Fig.4.2-1 A) that was corroborated 
by its biochemical characterization (Fig.4.2-2) since the biofilms formed in TSB supplemented 
with BC revealed a protein and polysaccharide content higher than the normal biofilms. Since 
extracellular polysaccharides and proteins are two of the major matrix components19,30, our data 
suggest that BC-adapted biofilms present a well-defined and strong EPS matrix. 
SEM pictures (Fig.4.2-3) confirmed this feature as it was well noticed a denser outward EPS 
matrix evolving bacteria, being this especially evident in P. aeruginosa and E. coli single biofilms. 
Based on these characteristics, it can be speculated that the presence of BC during biofilm 
formation may give rise to adapted biofilms with a stronger and cohesive structural conformation. 
EPS are a complex and extremely important component of biofilms, providing architectural 
structure and mechanical stability to the attached bacteria2. From the point of view of disinfection, 
this feature can represent an additional nuisance since biofilm matrix acts as shield to external 
stresses, limiting, for instance, the diffusion of antimicrobials. According to Branda et al.5, small 
changes in the environmental conditions may promote dramatic changes in biofilm architectures, 
being the environment where biofilms are developed responsible for the matrix composition. So, it 
can be concluded that the presence of BC in the liquid interface surrounding the single and binary 
biofilms during their establishment can be the environmental factor that changes biofilm surface 
structure, making the biofilm-associated bacteria possibly more tolerant to antimicrobials. 
In attempting to expand the understanding of biofilm cell physiology, the response of P. 
aeruginosa and E. coli entrapped in single and binary biofilms to BC treatment was examined. The 
BC concentration used for the subsequent attack of the established six-days-old biofilms was 
similar to that used for biofilm adaptation due to the fact 0.9 mM is already a high concentration 
when compared with the normally in-use BC concentration in cleaning products [1.0% (w/v)]25. 
Lindsay et al.28 referred that the growth of Pseudomonas spp with other strains might be beneficial 
as the EPS produced by Pseudomonas spp may confer some protection to the binary biofilm and 
thus protect it against sanitizer treatment28,37. In the present study, the data did not corroborate 
those studies, as the binary growth of biofilm does not seem to give any advantage or disadvantage 
concerning the response to the presence of BC during biofilm development or the BC challenge. 
The E. coli biofilms formed in normal conditions, i.e. in the absence of BC, seem to show less 
sensitivity to BC attack (Fig.4.2-1 C) presenting also more unwavering protein and polysaccharide 
content (Fig.4.2-2). Actually, a careful observation of the values obtained with the biochemical 
characterization of E. coli biofilms reveals that after BC treatment there is just a small reduction in 
these contents. In this case, the EPS matrix seems to be a crucial structural parameter for E. coli 
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biofilm stability and architecture providing a refuge for bacterial community5. The limited 
effectiveness of antimicrobials to eradicate the microorganisms of biofilm infections may be 
related to non-mutational or physiological conditions that allow survival, like those related to 
stationary-phase physiology, low oxygen and nutrient penetration, low penetration of 
antimicrobials or antibiotics and slow growth. This particular phenotype confers biofilms tolerance 
or recalcitrance15,20,27. 
P. aeruginosa is known to produce mainly alginate during EPS excretion2,9 and there are studies 
referring alginate overproduction during nitrogen limitation13 and after P. aeruginosa membrane 
perturbation induced by ethanol14. E. coli matrix is composed mainly of colanic acid11,16,38,44,48,51. 
Pringent-Combaret et al.38 reported that the copious amount of appendages present at the cell 
surface (such as curli in E. coli and type IV pili in P. aeruginosa) and the various exopolymers 
excreted by bacteria can also concentrate ionic molecules from the biofilm phase as the biofilm 
develops. These different cell appendages and matrix main components together with the possible 
different response of each strain to BC stress can be the reason for the different biofilm behaviour 
observed and it can also explain the ability of BC treatment to disrupt matrices. 
The maintenance of the number of entrapped-cells of BC-adapted biofilms (Fig.4.2-1 C) can be 
due to the protective effect of the cohesive matrix observed in SEM (Fig.4.2-3). In this study, E. 
coli biofilm-entrapped cells probably have undergone some kind of phenotypic change due to the 
fact of being part of a biofilm. In fact, the entrapped-cells of adapted biofilms appeared to be more 
sensitive to BC than the cells of normal biofilms. It can also be due to the difficulty of detecting 
persister cells by culturability methods27. According to a study of Mangalappalli-Illathu31, the 
regrowth of Salmonella enterica serovar Enteritidis after BC exposure was due to a small 
percentage of survivor cells that, after BC stress relief, were able to recover and multiply, being 
these survivors the sign of the so called persistence and regrowth of biofilms. 
When considering the antimicrobial effect of disinfectants, it is not merely the killing of bacteria 
that is of interest. Removal of biofilm from the surfaces is also important as residual sessile cells 
may facilitate rapid regrowth of new biofilms18. So, in conclusion, it appears that E. coli and P. 
aeruginosa entrapped in single and mixed biofilms may develop adaptive resistance to BC, 
noticeable by the over secretion of matrix components during biofilm development in presence of 
that antimicrobial product. Overall results clearly point out that BC had poor antimicrobial 
efficacy against E. coli and P. aeruginosa biofilms development and control. 
Knowing that the amount of matrix is one of the most important contributes to the virulence of 
biofilms, the use of BC as an antimicrobial agent should be avoided and special care should be 
taken when dealing with inappropriate doses of this antibacterial agent. The suitable concentration 
of antimicrobial should always be supported by experimental assays. Otherwise, biofilm 
establishment and bacteria virulence might be favoured, contributing, in this way, to the increased 
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prevalence of surface contamination and biofilm-associated infections. The data of this study did 
not allow the determination of which phenomenon (phenotypic adaptation, genetic acquired 
resistance or both) was responsible for the adaptation of biofilms to sub-lethal QAC exposure. 
Therefore, future work will be required to unravel the mechanism(s) by which the biofilm-
entrapped bacteria respond to environmental pressures. This can be achieved by the determination 
of genetic and proteomic regulation of EPS production under BC stress. 
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CHAPTER 5.1 
 
 PSEUDOMONAS AERUGINOSA PLANKTONIC ADAPTATION TO 
BENZALKONIUM CHLORIDE: A PROTEOMIC APPROACH 
This study aimed to assess the outer membrane modifications of planktonic Pseudomonas aeruginosa 
ATCC 10145 after continuous exposure of bacteria to increasing doses of benzalkonium chloride (BC). The 
proteome of two laboratory-adapted strains to two BC concentrations (0.9 and 12 mM) was characterized. 
Proteomic studies revealed that adaptation select some changes in the membrane proteome, these alterations 
being BC concentration dependent. BC adapted cells differentially expressed seven outer membrane 
proteins. OprF and two hypothetical proteins (PA1041 and PA2800), OprE3, OprL and OprI and OprG. 
Some of these proteins are porins and have key roles in multidrug efflux pumps, being related with antibiotic 
resistance. Other are lipoproteins that are essential for cellular processes being also involved in P. 
aeruginosa mucoidity. 
The modification of the outer membrane proteins profile of the laboratory-adapted P. aeruginosa 
emphasizes that simple exposure to antimicrobial stress endorses differential expression of some key 
proteins related with membrane permeability function that may thus have impact in bacteria pathogenicity. 
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5.1.1 INTRODUCTION 
Many processes essential for P. aeruginosa pathogenesis, e.g., nutrient uptake, antimicrobial 
resistance and virulence, take place in the cell envelope and depend on components residing in the 
periplasmic space16. 
P. aeruginosa is often intrinsically resistant to antimicrobials, especially because this bacterium 
has low-permeability membrane barriers29. Industry is permanently trying to find agents that can 
be effective in bacteria eradication and able to be extremely successful by acting in less specific 
resistance mechanisms like the permeability barriers and multidrug active efflux29. 
Antimicrobial chemical agents are widely employed to reduce microbial levels on inanimate 
objects and may occasionally act as chemosterilants, some being employed as high-level 
disinfectants41. It has been reported in literature that the widespread use of biocides and 
disinfectants in hospitals, and to a lesser extent at home, could act as a selective pressure for 
antimicrobial-resistant bacteria41. Some authors20,28 refer to hospital sinks, where disinfectants and 
detergents are discarded, as one of the main environmental sources of several P. aeruginosa 
resistant strains responsible for outbreaks in clinical settings. Antimicrobial agents can cause 
significant membrane damage, namely disorganization25 or rupture in gram-negative bacteria42. 
Benzalkonium chloride (BC) has been shown to cause changes in the outer membrane 
permeability and can lead to bacterial resistance to that or to other antimicrobial agents1. 
Due to their interfacial position in cells, membrane proteins are central to cell life because they are 
in the interface between the outside and the inside of the cell36, playing important roles in various 
cellular processes including signal transduction, metabolites and ions transport and cell adhesion45. 
Membrane proteins are very important for pharmacological action because they represent potential 
targets for vaccine development 44. The membrane is also a protective barrier and constitutes more 
than half of all known drug targets49. 
One of the factors that can contribute to the understanding of the parameters involved in sanitation 
failure is to establish whether the repeated contact of bacteria with a chemical can select changes 
in its proteomic traits. So, the purpose of this study was to examine the outer membrane (OM) 
proteome modifications promoted by the adaptation of P. aeruginosa to BC and to correlate them 
with the increased tolerance showed by those strains. 
 
5.1.2 MATERIAL AND METHODS 
Strains and culture conditions and antimicrobials  
P. aeruginosa (ATCC 10145) and adapted to 0.9 mM and 12 mM of benzalkonium chloride (BC) 
(obtained as described in sub-chapter 2.2.2) strains were used throughout this work. 
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Proteomic analysis 
Preparation and analysis of outer membrane protein (OMP) extracts 
Crude OMP extracts were prepared from bacterial pellets following the spheroplast procedure 
described by Mizuno and Kageyama26 in sub-chapter 2.5.1. 
Two-dimensional gel electrophoresis 
OMP patterns were analysed by two-dimensional gel electrophoresis (2-DE) as described in sub-
chapter 2.5.2. 
Gel analysis and protein identification 
Spot quantification was achieved by computing scanning densitometry and spots were excised 
from the polyacrylamide gel and identified as described in sub-chapters 2.5.3 and 2.5.4 
respectively. 
Bioinformatic tools for subcellular location 
For the identified proteins, and in particular for unknown proteins, the prediction of their location 
within the bacterial cell was obtained from the genome annotation of P. aeruginosa (accessible at 
http://www.pseudomonas.com/). 
5.1.3 RESULTS AND DISCUSSION 
Antimicrobial adaptation 
The stability of the BC-adapted cells (A0.9 and A12 strains) was determined after three transfers 
in TSB medium. After the de-adaptation process, the adapted strains lost their adaptive resistance, 
as they were unable to growth in TSA supplemented with BC after 10 passages in TSA. Joynson et 
al.18 referred that despite being easily attained, the adaptive resistance can be lost if bacteria are 
sub-cultured in the absence of the selection pressure. This seems to be a characteristic of bacterial 
adaptation achieved by continuous exposure. This feature was also reported by Gilleland et al.12 
who confirmed the instability of P. aeruginosa resistance as the strains readily revert to 
susceptible during several transfers in the absence of antibiotic. So, to keep the bacterial tolerance, 
A0.9 and A12 P. aeruginosa cultures were maintained in TSA supplemented with 0.9 and 12.0 
mM of BC, as referred in the Materials and Methods section. 
OMP patterns 
As BC is one if the antimicrobials which action occurs mainly at the bacterial outer membrane 
level47, this work investigated the changes induced by BC on the OMP pattern of P. aeruginosa. 
However, membrane proteins are notorious complex to analyse via 2-DE due to difficulties in 
extracting them from the membrane and their inherently hydrophobic nature27. The hydrophobicity 
of these proteins makes them also difficult to solubilise for isoelectric focusing (IEF). Moreover, 
they often precipitate at their pI (isolelectric point) in the IPG strip, reducing the transfer to the 
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second-dimension gel (2-D). The incorporation of the zwitterionic detergent ASB-14 in the 2-D 
sample solution prior to 2-DE has previously been shown to improve the solubility of the 
membrane proteins compared with sample solutions containing CHAPS or SB 3-104. In this study, 
ASB-14 was added to IEF buffer in order to increase the solubility of the proteins. 
In the present study, some proteins were found as mass isoforms (represented by * in Table 5.1-1). 
The isoforms exhibited different apparent molecular masses and pI values, witness of 
posttranslational modifications19. Thus, the major constitutive porin OprF was found as three 
isoforms, confirming previous observation45. It was also the case of OprL and OprG. The range of 
the membrane proteome alterations following adaptation is very low (about 11 %) i.e. 22 on 206 
spots which were discriminated on 2-DE gels and BC concentration dependent. 
Protein identification showed some of these spots correspond to cytosolic proteins, e.g. HemB, 
Ndk, PyrB, SucC, Tsf, PA4352 and PA 5339 (Table 5.1-1). The presence of these proteins in the 
bacterial samples pointed out cytoplasmic contaminations.  
Only four OMP (PA2800, OprF, OprL and OprI) exhibited different amounts in 0.9 mM BC-
adapted cells when compared with non-adapted organism, whereas seven OMP (PA2800, OprF, 
OprL, OprI, PA1041, OprG and OprE3) were differentially expressed in 12 mM adapted 
organisms  (Table 5.1-1). This observation is surprising considering the antimicrobial action of BC 
which is thought to involve a general perturbation of lipid bilayer membranes as the outer-
membrane of Gram-negative bacteria47, and the strategic role of the outer membrane in the cell 
adaptation to environmental stresses. BC binds firmly to anionic sites found on the membrane 
surface, causing the loss of osmoregulatory capacity as well as the leak of potassium ions and 
protons11. Therefore, in this study it was expected to find a higher number of membrane proteins 
with different expression in the adapted bacteria when compared with the OM profile of the 
reference strain. 
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OprF was up-regulated in both laboratory-adapted bacteria. This OM protein is non-covalently 
linked to peptidoglycan and it is involved in the maintenance of P. aeruginosa cell shape, having 
homology to another structural OMP, the OmpA from Escherichia coli51. It has been shown that 
the N-terminal domains of OprF from Pseudomonas strains are able to form ion channels in planar 
lipid bilayers similar to those induced by the OmpA N-terminal transmembrane domain43. Besides 
that, OprF is also a major environmental sensor13,50, with an important role in adaptation to 
hyperosmotic conditions13. However, the involvement of OprF in antibiotic resistance remains 
controversial2. It has been suggested that the loss of this protein may be involved in the multiple-
antibiotic resistance phenotype33,34. According with Jouenne et al.17, this protein loss also occurs 
when bacteria evolve from planktonic to biofilm mode of life, reflecting a tendency of the 
microorganism to limit the exchanges with the extracellular medium. In this study, the increase in 
the expression of this protein might be related with an increase of exchanges within the cell and 
the medium containing BC. 
Bacteria adapted to the higher BC concentration accumulated the probable OMP PA10141 (Table 
5.1-1) whose function is unknown. OprL and OprI were down-regulated in adapted P. aeruginosa 
for the two tested BC concentrations (Table 5.1-1). Lipoproteins, like OprL and OprI have been 
shown to play a role in many fundamental cellular processes and in the pathogenesis of several 
bacterial infections38. In P. aeruginosa, microarray analysis has revealed that there is a prominent 
induction of lipoprotein-encoding genes during mucoid conversion9,38. OprL is a peptidoglycan-
associated protein with strong immunogenicity and a key-protein for the identification of P. 
aeruginosa required to maintain OM integrity3,23 and cell morphology22,39,40 
OprI is a structural lipoprotein, essentially studied for its low variability between P. aeruginosa 
strains, which makes it useful as a phylogenetic marker7, as a potential vaccine37 and as an 
epidemic detection marker in the case of cystic fibrosis35. As an integral OM component, OprI 
plays a role in cell shape and membrane fluidity maintenance13. According to Linares et al.21, the 
exposure of P. aeruginosa to tobramycin and ciprofloxacin also promoted the down-regulation of 
the OprI protein. 
The underexpression of such important proteins in adapted cells can be a sign of disruption of the 
OM and loss of morphology after antimicrobial stress. Moreover, it might reflect some changes in 
P. aeruginosa mucoidity. 
Bacteria adapted to 12 mM of BC also under-expressed OprG, OprE3 and the probable OMP 
PA2760 with unknown function46 (Table 5.1-1). These OMP are frequently described as involved 
in antibiotic resistant and act as porins playing an important role in multidrug efflux32. OprG 
expression is highly dependent on growth conditions14, including temperature and medium 
osmolarity13 and magnesium10 and iron53 concentration. Additionally, this protein has been 
suggested to be involved on modifications of the lipopolysaccharide layer10 in P. aeruginosa. 
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There is some controversy regarding the involvement of OprG protein expression in bacterial 
resistance to antimicrobial agents. Loughlin et al.24 evaluated the effect of BC in P. aeruginosa 
protein patterns and had observed an accumulation of OprG. In contrast, more recent studies5,32 
showed that P. aeruginosa tolerance to kanamycin and tetracycline was associated with the down-
regulation of OprG32. 
OprE3 is a hypothetical protein with homology to the E. coli protein, b0681 that function as a 
porin of the outer membrane. The accumulation of OprE3, an anaerobically induced porin52, by 
biofilm P. aeruginosa cells has been reported48. 
Surprisingly, the conserved hypothetical protein PA2800, whose location is predicted in the outer 
membrane, was accumulated by the 0.9 mM BC-adapted cells, but down-regulated by the 12 mM 
BC-adapted ones (Table 5.1-1). The function of this protein is yet unknown. 
GroEL has been localized in the membrane and periplasm6,31 and in extracellular medium30. So, 
although this protein is predominantly cytoplasmic, it can be found in different cellular extracts. In 
fact, proteins belonging to the chaperon family, such as GroEL, have already been described as 
associated with the OM or even extracellular secretions1,8. Other studies indicated that this protein 
might be involved in the folding of membrane-associated proteins52 and in cell adherence15.  
Results showed that few OMP exhibited changes in their expression, suggesting that bacterial 
adaptation to BC do not mobilize outer membrane systems while its antimicrobial action mainly 
acts at the bacterial outer membrane level. In order to achieve better knowledge concerning 
bacterial adaptive resistance to BC and to other QAC, future proteomic characterization of 
subproteomes such as OM proteins, as well as the complete proteome analysis of P. aeruginosa 
would be of interest. 
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CHAPTER 5.2 
 
 
PROTEOMIC VIEW OF BIOFILM-ADAPTED PSEUDOMONAS AERUGINOSA 
TO BENZALKONIUM CHLORIDE AND CIPROFLOXACIN  
Adaptive resistance to antimicrobials has been widely reported in planktonic state and characterized in terms 
of phenotypic traits and proteomic modifications. Concerning biofilm adaptation and subsequent complex 
and specific biofilm resistance mechanisms, these are not fully understood. This work aimed to examine 
whether exposure of Pseudomonas aeruginosa biofilms to benzalkonium chloride (BC) and ciprofloxacin 
(CIP) during a laboratory adaptation process could induce any proteomic alteration in the outer membrane 
(OM) of the biofilm-growing cells. The understanding of the process on the basis of adaptive response of 
biofilms will help in gaining insights concerning the resistance mechanisms and the increased virulence of 
P. aeruginosa when growing in a biofilm. 
Biofilms were formed for 24 h being after submitted to the presence of 320 mg/L of BC and 6.0 mg/L of 
CIP, during 12 days. Sessile cells were separated from the matrix and the OM proteins patterns compared. 
Biofilm proteome analyses showed that P. aeruginosa adaptation to BC and CIP changed the expression of 
six proteins. Regarding outer membrane proteins, the biofilm exposure to both antimicrobials generated 
common down-regulation of only one OM protein: the putative tail sheath protein. The type 4 fimbrial 
biogenesis OM protein PilQ precursor was over-expressed only by biofilm cells submitted to BC. These 
alterations of the OM protein pattern probably contribute to exacerbate biofilm cells resistance. Since some 
phage proteins were found differentially expressed in adapted biofilms, more research concerning biofilm 
development in the presence and absence of antimicrobials is required to determine the localization and 
function of phage-related proteins. 
Some insights in the proteomic characterization were achieved, allowing the identification of several 
proteins that can be related with the increased virulence of P. aeruginosa and that can support future studies 
in this area. Results also show that the exposure to different products can promote the differentially 
expression of OM proteins, revealing a possible common response to stress supporting the phenomena of 
cross-resistance. However, it was not possible to describe completely the resistance mechanism, at the 
membrane level, responsible for bacterial adaptation and ability to growth in the presence of antimicrobials.  
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5.2.1 INTRODUCTION 
The Gram-negative bacterium Pseudomonas aeruginosa is a major cause of infection in 
hospitalized, burned, immunocompromised, and cystic fibrosis patients and is recurrently 
considered as a resistant organism14 and frequently develops resistance to antimicrobial agents 
during antimicrobial chemotherapy10. P. aeruginosa resistance is often associated with its high 
ability to attach to a surface, embedding itself in a matrix of exopolymeric substances9, containing 
also proteins, and nucleic acids31, establishing a biofilm. Bacteria embedded in biofilms are much 
more resistant to antimicrobials when compared with planktonic-growing cells22, being this 
complex increased tolerance not yet fully understood. However, several mechanisms have been 
recognized as playing major roles in biofilm resistance: the slow microbial growth rates; the 
intercellular signals that alter the biofilm physiology, causing bacteria to produce molecular pumps 
that expel antibiotics from the cells and allow the community to tolerate the presence of the drug; 
the diffusion barrier promoted by the biofilm matrix that prevents antimicrobial products to reach 
their targets, being also responsible of the neutralization or degradation of the antimicrobial and 
the specialized populations of persister cells. Some antimicrobial agents act by causing membrane 
damage, affecting membrane organization23 or rupture of biological membranes in gram-negative 
bacteria30. Also, the different expression of efflux pumps33 13, porins 7 and other proteins at the 
membrane level32 is related with the intracellular concentration of antimicrobials 5 and thus 
mediate resistance. Antimicrobial agents used to control biofilms, are usually applied in high doses 
and during long periods of time in order to achieve better efficiency. This procedure, when not 
fully efficient, tends to kill only external bacterial layers of biofilms, exposing the inner-entrapped 
biofilm cells to gradually reduced concentrations of the antimicrobial products. When biofilms that 
are not eradicated when these procedures are applied, the enclosed protected bacterial cells persist 
and instigate biofilm regrowth. This type of adaptive resistance to antimicrobials is a way of 
antimicrobial stress response and has been widely reported in planktonic growth and studied 
through phenotypic characterization and proteomic analyses. Concerning biofilm adaptation, the 
increased resistance and the resistance mechanisms at the membrane level of biofilm-entrapped 
cells to antimicrobial exposure has been scarcely studied.  
This work aimed to characterize the proteomic changes, induced at the membrane level, of P. 
aeruginosa cells that subsist in biofilms exposed to benzalkonium chloride (BC) and ciprofloxacin 
(CIP). These proteomic changes can help in the characterization of resistance mechanisms 
associated with biofilm adaptation and can allow the establishment of common proteome changes 
after the action of different classes of antimicrobials, which can help in the clarification of the 
cross-resistance mechanism to antibiotics that is known to occur after antimicrobial action. 
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5.2.2 MATERIAL AND METHODS 
Strain and culture conditions  
Pseudomonas aeruginosa (ATCC 10145) was used throughout this work. 
Biofilm development and adaptation 
The methodology used to grow the bacterial biofilms was based on the microtiter plate test 
developed by Stepanovic et al.35 as described in sub-chapter 2.4.1.3. Biofilms were adapted to 320 
mg/L (0.9 mM) of BC and 6.0 mg/L of CIP, as described in sub-chapter 2.4.2 during 12 days. 
After that, the content of each well was removed and biofilms were washed twice with 2 mL with 
UP water. Non-adapted biofilms were developed in wells containing 2 mL of TSB for the same 
period of time. The biofilms were scraped using a sterile rubber scraper, until the wells were 
visually clear, and the biofilms were resuspended in UP water and vortexed vigorously for 2 min.  
Proteomic analysis 
Preparation and analysis of outer membrane protein (OMP) extracts 
Bacterial cultures and matrix were separated and bacterial membranes were extracted according to 
the method described by Winder et al.39 as described in sub-chapter 2.5.2. 
Two-dimensional gel electrophoresis 
OM protein patterns were analysed by two-dimensional gel electrophoresis (2-DE) as described in 
sub-chapter 2.5.2. 
Gel analysis and Protein identification 
Spot quantification was achieved by computing scanning densitometry and spots were excised 
from the polyacrylamide gel and identified as described in sub-chapters 2.5.3 and 2.5.4, 
respectively. 
Bioinformatic tools for subcellular location 
For identified proteins, and in particular for unknown proteins, the prediction of their location 
within the bacterial cell was obtained from the genome annotation of P. aeruginosa (accessible at 
http://www.pseudomonas.com). 
5.2.3 RESULTS AND DISCUSSION 
Some reports refer that the widespread use of biocides and disinfectants in hospitals, and to a 
lesser extent at home, could act as selective pressure for antimicrobial-resistant bacteria29. The 
present study aimed to investigate the stress response of sessile bacteria when exposed to two 
different antimicrobials, BC (a biocide) and CIP (an antibiotic). As the cell envelope plays a key 
role in bacterial responses to environmental stresses1,20,21,34, the proteomic approach was focused on 
OMP profile alterations induced by antimicrobials exposure. It has been shown that permeability 
changes are frequently caused by BC exposure and can lead to bacterial resistance to this or to 
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other antimicrobial agent6.  High doses of antimicrobials were used in order to cause damage in 
cells and also to ensure the selection of P. aeruginosa biofilm cells that were able to survive upon 
a long exposure to these antimicrobial agents.  
Proteomic studies on biofilms normally comprise the characterization of the alterations of the 
protein patterns between planktonic and sessile organisms and during the different developmental 
biofilm stage8,26,37. In this study, the proteomic characterization of the OM of the biofilm-growing 
cells challenged for 12 days with supra-minimum inhibitory concentrations of two antimicrobials 
was assessed. The main difficulty of this task was related with the reduced number of bacteria that 
persist within the stressed biofilm and, in consequence the reduced concentration of OM proteins 
obtained after the extraction procedure. Additionally, the separation of bacterial cells from the 
biofilm matrix may also have led to sample contamination. This difficulty became even higher 
when biofilms were developed under the chemical stress since more extracellular polymeric 
substances are secreted by bacteria in order to defend the surviving cells from the aggression22. 
Consequently, an increase in samples contaminants was observed. 
The protein expression of the biofilm-growing bacteria challenged by BC and CIP is listed in 
Table 5.2-1 and shown in Fig.5.2-2. The experimental OMP characterization discriminated nearly 
600 proteins with p<0.05 and fold>2 (Fig.5.2-1). However, and due to the small number of gels 
that could be analysed for each condition, it was also considered the q value (q ≤ 0.05) to 
guarantee that no false positives were mistakenly analysed. The examination of the OM profiles of 
BC- and CIP-adapted cells showed changes in the expression of a small number of proteins 
(Fig.5.2-2). The name of the altered proteins is given in Table 5.2-1 
 
Fig.5.2-1 Silver-stained experimental 2-DE map obtained with an OM extract of P. aeruginosa 
biofilm cells (protein loading 200 μg).  
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The analysis of the biofilm cells proteome showed that sessile P. aeruginosa adaptation to both 
BC and CIP endorsed changes in ten OMPs (Table 5.2-1) (i.e., 1.6% of the membranome), when 
compared with the proteome of the non-adapted biofilm counterparts. These data suggest that 
antimicrobials induced small alterations in the OMP patterns of the biofilm adapted organisms. 
This may be the consequence of the accumulation of stress proteins by biofilm-growing cells even 
in the absence of antimicrobials. Indeed, it has been shown that some OMP involved in the 
adaptation process were overexpressed by biofilms organisms, probably due to alterations in the 
environmental conditions prevailing within biofilms8. 
Down-regulated proteins 
Biofilm exposure to both antimicrobials generated common down-regulation of four main 
proteins: GroEL (and the chain A crystal structure of the asymmetric chaperonin complex 
GroelGROES), predicted major capsid protein, putative tail sheath protein, and a hypothetical 
protein PA0537 revealing a possible similar stress response (Table 5.2-1).  
GroEL was found in several gels spots (3241, 3407, 4114), as well as putative tail sheath protein 
(4186, 4306) (Table 5.2-1). A different position in a 2-DE gel (Fig.5.2-1) is the result of a different 
chemical structure of the protein, with each covalent chemical modification leading to a “new” 
protein species16. Thus these spots may correspond to different protein species with 
posttranslational modifications16. GroEL has been localized in several sites of the membrane, 
cytoplasm and periplasm27. So, although this protein is predominantly cytoplasmic, it can be found 
in different cellular extracts. In fact, proteins belonging to the chaperon family, such as GroEL 
have already been described as associated with the OM or even extracellular secretions14,17. Other 
studies indicated that this protein facilitates the folding process of membrane associated proteins11, 
as well as the adhesion of bacteria to tissues12. This protein is downregulated in bacteria from both 
adapted biofilms, the amount decrease being larger in BC than in the CIP adapted sessil P. 
aeruginosa. The downregulation of this chaperon protein in the presence of antimicrobials is quite 
unpredicted in the light of its role in bacterial adaptation36, since antimicrobials act at the outer 
membrane level, being expected higher folding of proteins related with this bacterial compartment. 
The major capsid protein and putative tail sheath proteins, that were also under-expressed in BC 
and CIP adapted cells (Fig.5.2-2, Table 5.2-1), have unknown function(s) and are encoded by 
genes that are part of a previously described genomic island (GI), PAGI-62. This GI is an example 
of a prophage that has undergone multiple recombination and deletion events resulting in P. 
aeruginosa altered virulence19. The putative tail sheath protein has been also associated with 
membrane vesicles (MV) produced by pathogenic bacteria and known to contain active toxins and 
other virulence factors3. In the literature there is no consistent information regarding the 
expression of this proteins in biofilms. However, the fact that P. aeruginosa biofilm cells 
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underexpress this protein under stress caused by antimicrobials suggests the loss of biofilm 
membrane vesicles during the adaptation process. In the literature there is no consistent 
information regarding the expression of this proteins in biofilms. The underexpression of such 
important proteins might be a reflect of the ability of P. aeruginosa biofilms to adapt and inhabit 
extreme environments2. A hypothetical protein, PA0537, was also underexpressed in biofilm-
growing cells exposed to antimicrobial pressure (Fig.5.2-2; Table 5.2-1).). The function of this 
protein is still unknown. 
 TSB BC CIP 
Chain A, Crystal Structure Of The Asymmetric Chaperonin Complex 
GroelGROES(ADP)7 
   
GroEL 
   
GroEL 
   
Putative tail sheath protein 
   
Putative tail sheath protein 
   
Hypothetical protein PA0537 
   
Predicted major capsid protein 
   
Predicted major capsid protein 
   
Probable bacteriophage protein 
   
Type IV fimbrial biogenesis outer membrane protein PilQ precursor 
   
Fig.5.2-2 Comparison of the behaviour of selected proteins in P. aeruginosa biofilm-cells of grown in TSB and adapted 
to BC and CIP. 
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Differentially expressed proteins 
The type 4 fimbrial biogenesis outer membrane protein PilQ precursor was over-expressed only in 
biofilms exposed to BC (Fig.5.2-2, Table 5.2-1), while the probable bacteriophage protein was 
overexpressed in biofilms exposed to CIP (Fig.5.2-2, Table 5.2-1).  
Bacteriophage protein is, as the putative tail sheath protein, a MV protein of P. aeruginosa. 
Membrane vesicles are naturally released from the bacterial outer surface and are constituted of 
OM proteins, lipopolysaccharides and periplasmic components. P. aeruginosa MV are a 
component of the matrix of the P. aeruginosa mature biofilm and contain some virulence factors, 
including proteases, phospholipase C, alkaline phosphatase, and antibacterial factors24. 
The PilQ protein is involved in type IV pilus biogenesis25, being essential for P. aeruginosa pilus 
formation and thus it can affect motility and adhesion25. This protein was overexpressed in BC-
adapted biofilm-cells although it was underexpressed in CIP-adapted biofilm-entrapped cells 
(Fig.5.2-2, Table 5.2-1). Nde et al.25 reported the downregulation of the gene PilQ after P. 
aeruginosa exposure for 60 min to chlorhexidine diacetate (CHX). According to this author, the 
mechanism of action of CHX in P. aeruginosa involves changes in outer membrane permeability. 
Although BC and CHX have similar action at the membrane level, in this work bacteria were 
grown as biofilms that were after exposed to antimicrobials while in the study of Nde et al.25, 
planktonic bacteria were grown in CHX. This different mode of growth can be on the basis of the 
contrary expression of this protein after antimicrobial exposure. 
Several studies have suggested that the most highly activated genes in sessile bacteria are those of 
temperate bacteriophages15,38. These take part in the diversification and phenotypic variation, 
including the production of small colony variants phenotypes28. The fact that biofilms were 
developed under antimicrobial stress could regulate proteins related with phages that may be in the 
origin of increased population diversity found within biofilms4. The phenotypic diversity amongst 
a biofilm population can intensify virulence factors like adhesion, hydrophobicity, swimming and 
twitching motilities18 increasing also the ability of a biofilm to survive under stress conditions. 
A proteomic approach was here used to characterize the alterations of the outer membrane 
proteome of P. aeruginosa biofilm cells after BC and CIP adaptation. When bacteria are within 
biofilms and exposed to chemical stress, the regulation of OM proteins expression can contribute 
to the increase of bacterial virulence and biofilm antimicrobial resistance. Herein proteins involved 
in pili biogenesis, vesicle formation, pathogenicity islands and some phage related proteins were 
identified in BC and CIP adapted P. aeruginosa biofilms.  
The number of differentially expressed proteins obtained after OM extraction of biofilm cells 
adapted to BC and CIP was not enough to clearly describe the resistance mechanism associated 
with this in vitro adaptive response. However, this work gave some insights that can support future 
studies in this area since it was observed the differentially expression of some OM proteins after 
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exposure to both antimicrobials, revealing a possible link between the response of bacteria within 
biofilms when exposed to external stresses. Further proteome studies will provide more 
comprehensive information on protein variations and reveal antibacterial resistance mechanisms, 
allowing the identification of candidate target proteins for novel antibiotics and defining some 
possible cross-resistance mechanisms associated with both antimicrobial products. 
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CONCLUDING REMARKS AND FUTURE PRESPECTIVES 
  In this Chapter, the major conclusions of the present thesis are addressed. Suggestions for 
future work are also proposed. 
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In clinical settings, bacteria with increased resistance may represent an augmented risk, as it can 
lead to infection outbreaks due to unexpected disinfection failures9, being also directly involved in 
the increase of morbidity and mortality caused by infection diseases1.  
In real scenarios and within the bacterial biofilm community, multiple types of bacterial isolates 
are undoubtedly present conferring greater phenotypic variability that contributes to biofilm 
adaptation to external antimicrobial pressures and subsequent biofilm persistence to antimicrobial 
treatments. As shown in Chapter 3.1, clinical isolates possess particular motility ability, thus 
influencing the biofilm mode of life. Since P. aeruginosa appendages can be related with higher 
bacterial virulence and probably subsequent increased resistance, future studies could be 
performed in order to genetically characterize the presence and loss of appendages in bacteria 
during the different stages of biofilm formation, and under different antimicrobial treatments. 
Moreover, due to the reappearance of motility appendages after loss (e.g., when bacteria disperse 
from biofilms to planktonic state) together with their function in adhesion to surfaces and adhesion 
to host tissues, it would be of great interest to determine the role of those appendages in biofilm 
formation. 
Antimicrobial resistance of P. aeruginosa biofilms appears to be complex and multifactorial and 
essentially instigated by: (i) the diffusional difficulty of the antimicrobial agents to penetrate the 
biofilm, (ii) the slow growing cells at the deeper layers of the biofilm, owing to limited oxygen 
and nutrients, as well as the (iii) presence of a great phenotypic variability of cells, being some of 
them persister cells6, that neither dye nor reproduce themselves in stressful conditions, but become 
active when stress is relieved. Persister cell formation and the reason why this particular 
phenotype shows increased resistance remain unknown, but their selection may occur via multiple 
pathways and be encouraged by growth conditions and environmental stresses15. Results obtained 
in Chapter 3.2, highlighted the importance of evaluating the biofilm capacity to regrowth after 
exposure to antimicrobial products. The existence of this type of cycle of dead followed by cell 
regrowth, together with the selection of cells that did not died, mostly due to protection conferred 
by the biofilm niche, may be responsible for contamination outbreaks when external pressure is 
released. Moreover persister cells that survive can be more resistant to antimicrobials leading to 
the selection of resistant strains. In light of these findings, it may be interesting to continue this 
work, by evaluating the resistance of biofilm cells that are released from the biofilm during the 
several steps of the regrowth cycle, with special care in analysing also phenotypic characteristics 
of the cells that are able to survive until the last pressure is applied. In a recent study6, the selection 
of this type of slow-growing or non-dividing cells is shown to be a result of toxin-antitoxin (TA) 
system that gives bacteria the possibility to “turn off” cell death. Studies concerning persister cell 
selection and TA characterization would also be an attractive challenge. 
Various mechanisms have been reported to play, either singly or synergistically, roles in bacterial 
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adaptive responses to antimicrobials. The presence of low antimicrobial concentrations can be one 
of the reasons that support bacterial adaptive resistance (Chapter 4). Microorganisms may have 
multiple, possibly interconnected, adaptive mechanisms depending on the nature of the 
antimicrobial agent. These adaptive mechanisms can include: i) alterations in outer membrane 
proteins, ii) antimicrobial uptake, iii) cell surface charge and hydrophobicity, (iv) and fatty acid 
content of the cytoplasmatic membrane7. Despite the existence of several novel anti-pseudomonal 
agents (e.g.: cationic antimicrobial compounds, efflux pump inhibitors and phage therapy), there 
will always be a lack of effective solutions to control biofilm formation and even to eradicate it. 
Preventive measures in areas like antimicrobial stewardship, resistance surveillance and infection 
control should be applied in order to control biofilm formation12. Surface coating or conditioning 
of intravascular catheter (IVC) is one of the most recent advances used to impair microbial 
adhesion, as suggested by a recently published work of Zhang et al.18. This author also highlights 
the importance of balancing the cost-benefit of surface conditioning since despite conditioning 
with antimicrobials or antibiotics could reduce the risk of IVC-related infection and biofilm 
formation, they can also increase the risk of emergence of antimicrobial resistance. Concerning the 
BC residue deposition as a conditioning film in PS surfaces (Chapter 4.1), it is shown that the 
existence of residues on the surfaces alters hydrophobicity and modifies the surface properties of 
both entities (bacteria and surface) favouring bacterial adhesion. These findings suggest that the 
unintentional deposition of residual antimicrobials on surfaces after cleaning procedures should be 
carefully studied as it may encourage bacterial adhesion, especially of bacteria that have been 
previously exposed to chemical stresses. In order to completely characterize the potential 
application of BC conditioning on PS surfaces, it would be interesting to study: (i) what is the 
ideal period of contact between the biocide and the surface (t) and the best concentration (C), 
determining the most advantageous C(t) relation; (ii) the biocide concentration at the surface after 
conditioning; (iii) the use of other types of surfaces, as well as other microorganism or 
combination of microorganisms. The answers obtained can give positive insights regarding the 
possible and positive use of this or other biocides as agents that impair adhesion in other types of 
surfaces and areas where biofilm control is required.  
The studies presented in Chapter 4.2 highlighted that two different bacterial species could live 
synergistically in a biofilm, giving rise to a new distinct biofilm population with different 
behaviour when facing antimicrobial products action. The continuous exposure of these bacterial 
consortia to antimicrobials leads to the development of biofilms encompassing more virulent and 
tolerant bacteria. Furthermore the existence within a biofilm of multiple bacterial species can 
facilitate gene transfer and also the occurrence of plasmid dispersal by conjugation, due to the 
higher population density, which might stimulate biofilm development and increase biofilm 
stability10. After BC biofilm adaptation more cohesive biofilms were observed being the augment 
of the matrix amount the greater difference in adapted vs normal biofilms. This study raised some 
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issues that would be interesting to address: (i) to characterize the matrix structure and composition, 
namely the polysaccharides, proteins and eDNA. Since P. aeruginosa during EPS production, 
secretes mainly alginate13 and E. coli matrix is composed largely of colanic acid19, molecular 
studies, based on these genes expression would be important to identify the secreted factors in the 
several stages of binary biofilm development as well as to identify possible target genes of interest 
to develop new antimicrobial agents, (ii) it would be also interesting to elucidate the contribution 
of each individual microorganism along the biofilm development time, as well as the biofilm 
resistance in several time-periods. This will allow a deeper characterization of the symbiotic 
relationship between those microorganisms as well as the contribution for resistance of each 
microorganism as being part of a binary biofilm, (iii) when analysing experiments with mixed 
biofilms, it urges also the need to study other types of microorganism combination that can take 
part in the biofilm consortia as well as the possible solution to eradicate these polymicrobial 
biofilms. In fact, in real situation microorganisms associate themselves in mixed-species biofilms, 
as in device-related infections14, chronic otitis media3, cystic fibrosis and also in chronic wounds11 
so, it would be interesting to study multiple bacterial species combinations, that mimic real 
biofilms. 
Pseudomonas aeruginosa adaptive resistance is a phenomenon that is simply to attain by bacterial 
exposure to increasing concentration of antimicrobial agents, as the works of this thesis confirmed. 
However, adapted bacteria are unstable and tend to revert to their susceptible phenotypes, being 
the molecular mechanisms that contribute to these phenotypic changes unclear17. The outer 
membrane protein profile of the BC-adapted strain was studied in order to elucidate the 
extraordinary versatility and mechanism of adaptation of P. aeruginosa (Chapter 5.1). Results 
showed that P. aeruginosa adaptation to BC does not seem to endorse proteomic changes at 
membrane level. Future works should comprise technique improvements, in order to increase the 
knowledge in adapted bacteria selection and outer membrane protein separation. Moreover, 
adaptation to other biocides can also be studied and adapted P. aeruginosa total proteome must be 
studied. The proteomic characterization of adapted biofilms to biocides (BC) and antibiotics (CIP) 
was studied in the scope of this thesis (Chapter 5.2), since very little information is available on 
the cross resistance of sessile bacteria to antibiotics and biocides. Although proteomic studies 
(Chapter 5) began to dissect P. aeruginosa adaptive resistance mechanisms, further studies should 
be addressed in order to understand how the protein functions relates with adaptive resistance and 
how the regulatory network permits them to be expressed when they are needed. Moreover, and 
due to the difficulties felt during protein extraction and also in obtaining enough outer membrane 
protein concentration, mainly due to the small amount of biofilm that can be produced and adapted 
in vitro, the already available protein extraction techniques should be improved and customized for 
biofilms. Furthermore, studies regarding biofilm matrix proteome should also be performed as 
they may answer some important questions related with biofilms increased resistance after 
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antimicrobial exposure. In the case of sample preparation of matrix proteins, as this type of sample 
shows high content of contaminants, such as polysaccharides and eDNA, special care should be 
taken in order to obtain a clean sample without loss of protein amount representativeness. 
Moreover, it would be interesting to understand what are the proteomic changes induced at 
membrane level in isolated strains, wild-type bacteria as well as bacteria adapted to the products 
used during medical devices cleaning procedures, in order to understand if the resistance 
mechanism, as well as the natural selection phenomena is similar for each type of microorganism.  
In summary, the information resulting from this thesis contributes to a better understanding of the 
phenotypic changes in P. aeruginosa cells when exposed to antimicrobial agents, especially when 
established in biofilms. It is though to have contributed to the increase of the knowledge on P. 
aeruginosa clinical isolates behaviour when exposed to stress (Chapter 3), on specific changes 
induced by biofilm adaptation, namely in polysaccharides content (Chapter 4), and cell surface 
hydrophobicity (Chapter 4), as well as in outer membrane protein profiles (Chapter 5). These 
findings can be the start to new investigations that can lead to a better understanding of bacteria 
adaptive resistance and to the development of new strategies that can be applied in biofilm control, 
to impair its formation and to eradicate already established biofilms.  
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